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  Magnetoelastic devices have potential utility as sensors and actuators in implanted 
biomedical applications because of their inherent passive wireless nature which avoids the need 
for batteries and simplifies the implanted module. This work focuses on addressing system level 
challenges in two applications, one requiring an actuator and one a sensor.  The first application is 
mitigation of glaucoma valve encapsulation; challenges addressed in this application include the 
integration of an actuator onto the valve and especially the development of an acoustomagnetic 
interrogation module for verifying actuator functionality. The second application is biliary stent 
monitoring; challenges include protection of the sensor during and after deployment, and 
development of an interrogation module with vastly increased wireless range. 
 An Ahmed glaucoma valve (AGV) is used in the treatment of glaucoma to drain fluid from 
the eye and decrease the elevated intraocular pressure.  However, adhesion of cells and 
encapsulation of the AGV often lead to its failure.  The magnetoelastic system described in this 
work consists of a magnetoelastic actuator integrated onto the AGV that can agitate the nearby 
liquid and potentially mitigate encapsulation, and an interrogation module to excite the actuator.  
The interrogation module addresses the signal feedthrough and clinical utility challenges by 
implementing physical domain decoupling and tailored signal processing.  The in situ experiments 
with the system resulted in the first recorded acoustic signatures from a magnetoelastic sensor in 
an implanted environment; the measured signal-to-noise ratio was 3-6.  In vivo experiments 
performed on live rabbits along with the in situ results indicate that the magnetoelastic system does 
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not adversely affect the health of the animal and can feasibly provide sufficient wireless range and 
actuation amplitudes after implantation.  
 A magnetoelastic system for biliary stent monitoring consists of a magnetoelastic sensor 
integrated into the stent, and an interrogation module to communicate with the sensor.  The change 
in the resonant response of the sensor by mass loading and viscosity shifts due to sludge 
accumulation can diagnose early occlusion and allow timely intervention. 
 A self-biased sensor is designed and fabricated, decreasing the footprint considerably while 
preserving its resonant frequency. In vitro experiments mimicking sludge accumulation were 
performed, and the ratio of the shift in resonant frequency to the quality factor was found to be 
well-correlated with occlusion. The receiver operator characteristic of this parameter indicated an 
accuracy of 97.84% for a detection threshold of 50% decrease in flow rate through the stent due 
to occlusion. To protect the sensor during and after endoscopic deployment, a Nitinol reinforced 
polymer hybrid package is designed and used. In vitro tests utilizing bile-resistant bacterial 
cultures were conducted to evaluate the effect of the packaged sensor itself on the stent occlusion 
dynamics. Non-inferiority statistical tests performed on the results indicate that the instrumented 
stent is not inferior to the normal stent in terms of the occlusion time (p-value <0.05). 
 The implementation of the interrogation module addresses challenges, including wireless 
range, signal feedthrough, and clinical utility, and these are solved in part by time domain 
decoupling and signal processing techniques. The complete magnetoelastic system was 
successfully demonstrated in vivo, with the sensor-integrated stent implanted in the bile duct of a 
live pig at a wireless range of ≈17.15 cm with a signal to noise ratio ≈106. These are the first 




1. Chapter 1: Introduction 
1.1 Magnetoelastic sensors and actuators 
 Magnetoelastic devices are widely used as anti-theft tags in the retail sector.  Expanding 
the use of these devices as sensors or actuators in different applications has recently been an area 
of study.  Magnetoelastic sensors have been shown to be useful for environmental sensing, with 
measurands including temperature, pressure, and humidity [Gri99a, Gri00a, Kou00].  They have 
also been used for sensing physical properties like viscosity and density [Gri00b].  Several 
chemical/biological which use magnetoelastic devices have also been reported [Cai04, Rua04, 
Cai01].  Implanted biosensor applications have been explored for viscosity sensing, muscle stress 
sensing, and peripheral artery monitoring [Gur07, Pin01, Vis13].   
 In particular, magnetoelastic devices are attractive for implanted biomedical applications 
due to their inherent passive and wireless nature which eliminates the need for a battery implanted 
alongside the device [Gri99b, Ong05, Gre09a, Vis12, Pep15a, Nam17].  Additionally, the 
inherently wireless transduction mechanism eliminates the need for an implanted antenna.  Both 
features reduce implant complexity and size.  Another advantage is that these devices work at 
resonance, which helps to improve detection accuracy in noisy environments.  The low cost of 
amorphous metals, which is one of the best-suited classes of magnetoelastic materials, is an added 
advantage.  
 Magnetoelastic devices vibrate at their resonant frequency in response to an oscillating 
magnetic field applied at a frequency of mechanical resonance.  The vibration is due to the strain 
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caused by the alignment with an applied field of elongated magnetic domains that are tightly 
coupled with the material atomic structure.  The mechanical vibration of the magnetoelastic device, 
in turn, launches magnetic waves, which can be sensed externally by using an inductive coil 
[Gri02a].  This physical phenomenon follows the linearized constitutive relations coupling stress, 
strain, magnetic field, and magnetic flux density [Kat59]: 
[ ] [ ][ ] [ ][ ]Hds H .. += σε                                                         (1.1) 
[ ] [ ] [ ] [ ][ ]HdB T .σµσ +=                                                        (1.2) 
where [ε] is the strain tensor, [σ] is the stress tensor, [sH] is the compliance matrix at constant 
magnetic field intensity, [d] is the magnetostrictivity matrix, [H] is the magnetic field intensity, 
[B] is the magnetic flux density, [µσ] is the permeability matrix at constant stress.  These equations 
can be used in analytical modeling of the sensors or actuators [Gre09b, Pep15a] 
 A typical system consists of a magnetoelastic device and an interrogation module (Fig. 
1.1).  The magnetoelastic device can be either a sensor or an actuator, depending on the application.  
Magnetoelastic sensors are generally read by detecting resonant frequency shifts caused by the 
measurand, such as mass loading, changes in effective stiffness, or a change in viscosity/density 
of the medium surrounding the device.  An external interrogation module is used to excite the 
magnetoelastic device and sense the magnetic field or acoustic field generated from the sensor 
using an inductive coil or an acoustic sensor.  Although magnetoelastic actuators do not require 
measurement of the frequency response, its availability allows the verification of vibration or 




Fig. 1.1: A typical system consists of a magnetoelastic device and an interrogation module. 
  In spite of these advantages and interesting benefits of magnetoelastic devices, there are 
several open challenges in using these devices in implanted biomedical applications.  There are 
specific challenges associated with the design and fabrication of the magnetoelastic device, its 
integration to the implant module, and the development of an interrogation module for 
communicating with the implanted device.   
 A major challenge in device design and fabrication is miniaturization to reduce its impact 
while incorporating it into the implant module. The incorporated device must not introduce 
significant interference to the existing functionality of the implant module; for example, a sensor 
(device) meant to monitor stent occlusion should not vastly accelerate the occlusion of the stent 
(implant module). Also, the accommodation of the standard implantation procedure plays a major 
role in designing the device as well as a protective package if needed.   
 There are also specific challenges associated with the design and implementation of the 
interrogation module.  The excitation signal that is directly received by the receive coil can obscure 
the response of the implanted sensor and is termed signal feedthrough. Overcoming this 
feedthrough is one of the major challenges. The miniaturized sensor also poses the challenge of 
reduced wireless range due to reduced sensor response. Finally, the clinical utility of the 
interrogation module must also be considered for the practical implementation of these devices for 
implanted biomedical applications. 
4 
 
 This work focuses on two applications which are representative of these challenges. The 
first application is a magnetoelastic actuator that agitates liquid locally and minimizes fibrosis in 
glaucoma valves. This application has specific challenges in terms of integration of the actuator 
onto the valve and in terms of the interrogation approach for verifying the actuator functionality 
after implantation.  The second application investigated in this work is a magnetoelastic sensor for 
monitoring sludge deposition in biliary stents, which will help in diagnosing stent occlusion.  In 
this application, the specific challenge regarding sensor miniaturization is avoiding any effect of 
the sensor on existing stent functionality. The sensor protection while stent implantation is also 
another major challenge addressed in this work. Finally, the challenge of development of an 
interrogation module addressing signal feedthrough, wireless range, and clinical utility is 
addressed.  In the following sections, the backgrounds of – and open challenges facing – these 
specific applications are described in detail. 
1.2 Mitigation of glaucoma valve encapsulation 
1.2.1 Background 
One of the implantable applications of magnetoelastic devices targeted in this work is in 
the mitigation of glaucoma valve encapsulation.  Glaucoma is a leading cause of blindness in the 
world. One of the treatments for glaucoma involves implanting a mechanical valve in the eye, 
which drains the aqueous humor and reduces intraocular pressure.  However, this valve becomes 
encapsulated by fibrous tissue which leads to its eventual failure in as many as 72% of devices 
[Cvi16].  Recent efforts have proposed the integration of a magnetoelastic actuator onto this valve, 
and the mechanical vibrations of this valve can agitate the liquid around, minimizing the cell 
adhesion and subsequent encapsulation [Pep15b].  The actuator, along with an interrogation 
module to excite it and measure and verify its response, constitute a magnetoelastic system for this 
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application.  The open challenges associated with this system include the integration of the actuator 
onto the valve and the verification of actuation after implantation using the interrogation module.  
These challenges are addressed in this work. 
Glaucoma is an eye disease which is estimated to be affecting eighty million people 
worldwide by 2020; 11.1 million people are estimated to be bilaterally blind from glaucoma by 
2020 [Qui06].  The resistance to the outflow of aqueous humor (AH) from the eye that results in 
elevated intraocular pressure (IOP) is a major risk factor for the development of glaucoma 
[Roh83].  This elevated IOP results in damage to the optic nerve, leading to loss of peripheral 
vision and if left untreated, blindness.  One effective treatment of glaucoma is to surgically implant 
an Ahmed glaucoma valve (AGV), which is a mechanical valve that helps to lower IOP by creating 
a new pathway for AH to exit the eye [Ged07].  The AH exits through the lumen of the AGV and 
collects around the AGV, forming a reservoir.  Over time, adhesion of endothelial cells can lead 
to a fibrous capsule formation around the AGV which, in turn, limits the size of the reservoir and 
increases the resistance to AH outflow [Mol03, Eib05, Lee14, Cho10] (Fig. 1.2).   
 
Fig. 1.2: Schematic of implanted AGV on the eye (left). (b) Schematic of normal operation and 
encapsulation (right) [Pep15a]. 
Although several chemical and physical surface modifications have been proposed to limit 
fibrosis, these have mostly been ineffective [Par02].  Previously reported benchtop tests have 
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shown that magnetoelastic microactuators can locally agitate the fluid to potentially limit cell 
adhesion and fibrosis [Ito11, Vla11].  A magnetoelastic actuator can be integrated onto the valve 
which vibrates at its resonance frequency in the presence of an external magnetic field.  The 
vibrating actuator agitates the liquid around it.  This liquid agitation is intended to mitigate the 
adhesion of cells onto the valve and thus reduce the extent of fibrous encapsulation. 
An interrogation module is used to remotely interact with the implanted actuator. This 
interrogation module can either provide just an excitation to the actuator, or it can combine 
excitation of the actuator with some measurement of the actuator response.  An interrogation 
module which can verify the vibratory response from the actuators after implantation is useful.  
This verification would help to confirm the functionality of the actuator and can be used to adjust 
the therapeutic parameters.  For example, changes in the implanted environment, including tissue 
accumulation, can result in a resonant frequency shift.  By measuring the frequency response of 
the actuator with an interrogation module, a feedback loop can be used to adjust the actuation 
frequency accordingly. 
1.2.2 Challenges in actuator design and solution strategies 
There are several challenges associated with the design and fabrication of an actuator that 
can be integrated onto an AGV for this application. This actuator should have a small footprint in 
order to reduce its impact on the size of the valve and the implantation process.  The actuator also 
must be curved to conform to the surface of the valve to prevent further irritation of the eye.  
Previously reported works have utilized an annealing method using aspherical molds to curve the 
actuators [Pep15b].   
The integration of the actuator onto the AGV itself presents a challenge, and additionally, 
the actuator must be biocompatible and protected from corrosion since it is in a liquid environment.  
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Actuator coating techniques are investigated to address these challenges.  Mounting of the actuator 
onto the AGV must account for the dissimilarities in the two materials – the AGV is silicone rubber 
while the actuator is a metal alloy.  The effects of mounting to a high-mechanical-loss substrate – 
like silicone rubber – on the vibratory response of the actuator must also be considered and 
evaluated.  These challenges are investigated in this work.  
1.2.3 Challenges in interrogation and solution strategies 
The interrogation of the actuator for mitigation of glaucoma encapsulation poses several 
challenges due mainly to the aspherical actuator structure and immersion of the actuator in a fluidic 
environment. Three major challenges focused on here in this work include; (i) signal feedthrough; 
(ii) wireless range; and (iii) clinical utility.  The interrogation module developed in this work 
focuses on overcoming these challenges. 
One of the critical considerations associated with developing an interrogation module for 
magnetoelastic devices is the approach for reducing signal feedthrough.  The signal feedthrough 
is defined as the superposition of the excitation magnetic field on the sensor magnetic field at the 
receive coil. Physical domain decoupling is used to tackle the signal feedthrough issue in this 
application.  The magnetoelastic actuator of this application will vibrate at a resonant frequency in 
the presence of an excitation magnetic field at that frequency.  However, electromagnetic detection 
of the response cannot be applied with the particular actuators studied here.  This is because the 
flexural vibrational modes of the curved actuators have opposing strain patterns (i.e., some 
portions of the material is in tension while other nearby portions are in compression), resulting in 
a weak cumulative electromagnetic response.  As such, this work utilizes other means for detecting 
the frequency response of the actuator.  Initially, verification of actuation with a laser displacement 
sensor is investigated.  However, that method requires precise positioning of the laser onto the 
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actuator, and the laser may be obscured by tissue overlying the actuator in the implanted situation.  
Thus, this work further investigates an interrogation module that senses the acoustic signals from 
the magnetically excited actuator.  Actuation in the magnetic physical domain and sensing in the 
acoustic domain results in physical domain decoupling, which minimizes the signal feedthrough.   
The acoustic signal detected is noisy due to the presence of background signals and results 
in a low wireless range. The module developed in this work utilizes a series of digital signal 
processing steps to tackle this challenge and improve the wireless range.  Relative to laser 
displacement sensing, this acoustomagnetic and signal processing method has improved the SNR 
as well as eliminated the issues with precise positioning and movement of the eye, both of which 
are important for in vivo use.   
The in situ experiments indicate that the frequency shift after implantation is not 
significant, and hence, feedback is not necessary over a short-term period (Section 2.7).  As such, 
a simple patient-friendly module consisting of only the actuation capability (without feedback) is 
developed for the in vivo experiments.  A range of frequencies is used to excite the actuator, and 
this module only consists of the actuation mechanism with no response detection or feedback loop; 
this simplifies the module for ease of use in the clinical environment. In vivo experiments were 
performed on live rabbits as subjects. The in vivo results presented in this work indicate that the 
implanted actuator does not adversely affect the health of the animal. The in situ results indicate 




1.3 Biliary stent monitoring 
1.3.1 Background 
Another promising use of magnetoelastic systems is in biliary stent monitoring.  Plastic 
biliary stents are prone to occlusion due to sludge deposition in the stent.  Previous works have 
reported the integration of a magnetoelastic sensor into the stent for monitoring this sludge 
deposition [Gre07, Gre08, Gre09b, Gre10, Gre13], which will subsequently help in occlusion 
diagnosis.  However, these works have not addressed challenges in terms of miniaturizing the 
sensor, integrating the sensor into the stent, and increasing the distance from which the sensor can 
be interrogated while maintaining a strong signal to noise ratio (SNR).  The work here focuses on 
overcoming these challenges related to this specific application.  
 
Fig. 1.3: Schematic of sludge formation and stent occlusion for a biliary stent [Gre09b]. 
Typical plastic stents have the complication of stent occlusion due to “sludge” formation 
[Don07] (Fig. 1.3).  The bile duct carries the bile from the liver and gallbladder to the duodenum, 
which is a part of the small intestine.  A biliary stent relieves the constricted bile duct, with the 
stricture caused by pancreatitis, cholangitis, tumors, surgical injury, duct breakdown due to 
gallstones, collagen deposition, or duct tissue fibrosis [Lib96, Fra96].  At the beginning of 
occlusion, a protein layer starts to form on the stent surfaces.  Then, on this protein layer, bacteria 
starts to adhere, collects, and forms an extracellular biofilm and matrix.  The enzymes produced 
by the bacteria precipitate the cholesterol and calcium bilirubinate in the bile solution, and these 
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precipitates deposit in the extracellular matrix.  Altogether this matrix, biofilm, and bacteria form 
“sludge” which occludes the stent.  Solutions to this stent occlusion due to “sludge” formation are 
either stent replacement or insertion of another stent within the original stent. 
There are several medical methods for diagnosing stent occlusion.  One of the methods is 
a blood test known as a liver function test.  Abnormal levels of enzymes formed by the liver can 
be an indication of a malfunctioning liver due to the occluded stent.  However, this indirect 
measurement method can give an indication of occlusion very late or can indicate abnormal liver 
function not associated with the stent. Other methods include imaging by ultrasound or magnetic 
resonance, which can typically image only the outer surface of the stent and can detect occlusion 
at later stages based on bile duct dilation upstream of the stent.  However, these imaging methods 
are not effective at detailing the interior of the stent or at detecting early progression of occlusion.  
The integration of a magnetoelastic sensor has the potential to help in early occlusion detection 
and decisions on appropriate treatment, allowing the avoidance of both unnecessary stent 
replacements and high-risk infections.   
The magnetoelastic sensor integrated into the stent is remotely interrogated using an 
external interrogation module.  The wireless interrogation module induces resonant vibration and 
senses the magnetic field generated by the sensor, allowing the resonant frequency and quality 
factor to be determined.  These parameters are indicative of the sludge build-up. The resonant 
magnetoelastic sensor vibrates at maximum amplitude at its resonant frequency.  Any mass 
deposition due to sludge accumulation onto the sensor will result in a shift in this frequency as 




Fig. 1.4: Deposition of viscoelastic material onto the resonant sensor results in a shift in resonant 
frequency as well as (typically) a reduction of the quality factor. 
1.3.2 Challenges in sensor design and solution strategies 
There are several challenges associated with the design and fabrication of the 
magnetoelastic sensor and its integration to the stent for monitoring the biliary stent.  These 
include: (i) the miniaturization of the sensor without significant signal reduction; (ii) packaging of 
the sensor for protection during implantation and integration of the packaged sensor with the stent. 
Sensors must be small in order to be assembled in a biliary stent.  Typical plastic biliary 
stents have outer diameters 0.33 cm (10 Fr) or 0.38 cm (11.5 Fr), and the shape and size of the 
sensor need to be such that the sensor introduces minimal obstruction to the bile flow through the 
stent.  A solution to this is to have thin ribbon sensors along the inner sidewall of the stent.  The 
small cross section of these sensors is not expected to significantly affect the bile flow through the 
stent.  Long sensors can give better signal compared to shorter ones, but they are not ideal in this 
application because the stent tends to undergo tight longitudinal curvature during endoscopic 
deployment into the bile duct [Jia18b].  Long sensors are particularly stressed by this tight 
curvature, which can lead to sensor damage during implantation or a decrease in signal strength. 
While fabricating small sensors is straightforward, the critical challenge in miniaturization is that 
small sensors generate weaker signals at higher resonant frequencies.  These effects, in 
combination, add to the challenge in detecting signals from a miniaturized sensor at practical 
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wireless ranges. One of the main objectives of the sensor design presented in this work is to reduce 
the sensor footprint while maintaining the resonant frequency and preserving the signal amplitude. 
A simple approach to reduce the resonant frequency is to increase the length of the 
resonator, but this will also increase the size of the resonator, defeating the miniaturization goal. 
Reducing the stiffness of the resonator also decreases the resonant frequency. This can be done, 
for instance, by adding perforations to the structure, as examined in prior work on magnetoelastic 
sensors [Gre09b].  However, this approach typically introduces local areas of in-plane bending and 
requires removing material, both of which can have a negative effect on the signal amplitude. 
Alternatively, the effective mass can be increased to lower the resonant frequency. This can be 
done by attaching mass strategically, which is the method examined in this work. Also, a 
magnetoelastic sensor must be biased with a DC magnetic field for higher vibrational amplitudes. 
In general, the DC bias is either provided by external coils with DC current or small magnets 
placed next to the sensor.  External coils are not ideal for most wireless applications where the 
sensor position may vary because it is difficult to apply a consistent bias field externally, and also 
as the distance between the sensor and coil increases, high power is required to generate sufficient 
bias strength. However, placing small magnets adjacent to the sensor increases the total device 
footprint, and any small change in air gaps between the magnets and the sensor can significantly 
alter the sensor performance.  In this work, the mass loads on the sensor itself can acts as magnets, 
making the sensor self-biased. This helps in reducing the sensor footprint considerably while 
providing an extremely consistent DC bias.   
Another challenge is to protect the sensor during and after implantation.  The biliary stent 
is deployed in the bile duct by endoscopy.  These stents are available in various lengths, typically 
from 5 cm to 10 cm.  The stent and sensor need to pass through the endoscope during deployment.  
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During deployment, the stent and sensor are passed over an introducer – a relatively small, long 
tube that passes through the endoscope and is placed in the bile duct to act as a guide for the stent.  
The introducer itself has a diameter of 1.7 mm (for a 10 Fr stent) or 2 mm (for an 11.5 Fr stent).  
The introducer is a vital part of the stent delivery process, and its mechanical interaction directly 
with unprotected sensors is likely to cause damage [Gre13].  This indicates the need for a package 
to protect the sensor during implantation.   
There are a number of requirements for any such package. The package must be 
biocompatible and chemically inert such that it does not affect the tissue around it after 
implantation.  Also, it must be electromagnetically transparent so as not to affect the sensor signal.  
The stent goes through extreme longitudinal curvature when passing through the endoscope during 
the implantation procedure (Fig. 1.5(a)).  To withstand this tight radius of curvature (Rc ~2 cm), 
the sensor package must be flexible without being easily plastically deformed or damaged.  Also, 
the stent after implanted is under stress due to the anatomical curvature of the bile duct, as shown 
in Fig. 1.5(b). This bile duct curvature also tends to bend the compliant stent (Rc ~5 cm).  To keep 
the sensor straight in the stent, the package must be stiff enough to oppose the anatomical curvature 
and minimize signal attenuation due to sensor bending. Previous work used polymer structures to 
tackle this, but these structures were found to be either too flexible or too inelastic and thus 




Fig. 1.5: (a) Stent passing through the endoscope with elevator at maximum raised position, the 
radius of curvature (Rc) =2 cm. (b) Radiographic image of an implanted stent showing the inherent 
anatomical curvature of the bile duct with Rc =2 cm. 
This work uses a novel hybrid approach using a 3D printed polymer package with metal 
reinforcing features in order to meet the performance requirements. Benchtop and in vitro tests are 
used to evaluate the robustness of this package. The packaged sensor is bent in curvatures 
representative of those required during endoscopic deployment and in the bile duct anatomy. Of 
course, the addition of the package and sensor to the internal surfaces of the stent could lead to 
more rapid sludge development and negate the benefits of the sensing system. In vitro experiments 
are performed with test and control stents to evaluate the difference in the sludge development 
process in an instrumented stent relative to a non-instrumented stent. 
1.3.3 Challenges in interrogation and solution strategies 
The  challenges associated with the interrogation of magnetoelastic sensors for biliary stent 
monitoring are similar to those discussed in the previous section 1.2.3.  These challenges include 
(i) signal feedthrough; (ii) wireless range; and (iii) clinical utility. The specifics of this application 
change the nature of each of these challenges. The interrogation module developed in this work 
focuses on overcoming these challenges. 
  The issue of signal feedthrough results in the obscuration of the sensor signal, as shown 
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in Fig. 1.6.  The reduction of signal feedthrough can allow larger transmission fields and more 
sensitive receive circuitry, which can boost wireless range or enable sensor size reduction.  One 
approach to avoid this signal feedthrough issue is time domain decoupling.  With this method, the 
sensor is excited using a short transmitted burst, and then the ringdown response of the sensor is 
measured.  This is illustrated in Fig. 1.5.  This contrasts with a previously used method that used 
continuous transmission and reception and was limited by significant signal feedthrough as well 
as shifts in the electromagnetic characteristics of the media near the receive coil (for instance, due 
to respiration or movement of the patient) [Gre09b].   
 
Fig. 1.6:  Challenges in the interrogation of a magnetoelastic sensor and time-domain decoupling 
approach. 
While feedthrough can be significantly reduced with the time domain decoupling method 
and it has shown to be useful in the rapid interrogation of magnetoelastic strain sensors [Gri02b, 
She10, Pep17], there is a drawback to the method in the context of implantable resonators.  
Because such resonators are typically immersed in a viscous fluid, the quality factor of the 
resonance is relatively low.  During ringdown, this manifests itself as a low amplitude and quickly 
decaying signal envelope.  As such, the interrogation module must have sufficient sensitivity and 
transmit-to-receive switching speeds to capture this signal.     
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Another challenge in interrogating the implantable magnetoelastic sensors is the wireless 
range.  The magnetic field generated by the sensor decays rapidly with distance, which makes the 
detection extremely difficult at a longer range.  For example, the signal strength decreases 25-fold 
for a 1.5-fold increase in interrogation distance (Section 5.4.1).   Also, the magnetic field generated 
by the sensor decreases as the sensor size is scaled down.  A signal strength decrease of 15-fold is 
reported for a sensor with the length halved [Jia18b].  A series of digital signal processing 
techniques, along with careful hardware choices, are performed in this work in order to minimize 
the noise and achieve a high SNR.  A comparison of the wireless ranges achieved from sensors of 
various footprints in the previous works to those achieved in this work is illustrated in Fig. 1.7. 
 
Fig. 1.7: Comparison of wireless range and sensor size achieved in this work to previous works in 
magnetoelastic sensors.  
 Finally, the interrogation module design must consider clinical utility.  The interrogation 
time must be short for clinical tests, and the hardware components for testing must introduce 
17 
 
minimal inconvenience to the patient. The module must also accommodate anatomical variations 
in the position and orientation of the sensor with respect to the interrogation coils.  These points 
are considered while hardware implementation for the interrogation module.  
1.4 Organization of this report 
The two main goals for this thesis are: (i) investigate and demonstrate a magnetoelastic 
system for mitigation of glaucoma valve encapsulation in vitro, in situ, and in vivo. (ii) investigate 
and demonstrate a magnetoelastic system for biliary stent monitoring in vitro, in situ, and in vivo. 
This first chapter has introduced these two applications of magnetoelastic sensors and actuators: 
biliary stent monitoring and glaucoma valve encapsulation mitigation.  This chapter also presented 
the challenges associated with sensor design and fabrication, interrogation modules in both the 
applications and overarching goals for the work. These challenges are: 
• Integration of a magnetoelastic actuator onto a glaucoma valve 
• Implementation of an interrogation module for verification of implanted actuator 
• Design and fabrication of a miniaturized sensor for biliary stent 
• Design and fabrication of a protective package and packaged sensor integration onto stent 
• Implementation of an interrogation module for communicating with the implanted sensor 
  The remainder of this dissertation is organized as follows. The magnetoelastic system for 
mitigation of glaucoma valve encapsulation is discussed in chapter 2. Chapter 3 discusses the 
design and fabrication of the miniaturized sensor for biliary stent monitoring system. The design 
and fabrication of the in-stent hybrid package for protecting the sensor are discussed in chapter 4. 
Chapter 5 discusses the interrogation module developed for the biliary stent monitoring system 
18 
 
and the demonstration of the complete system in vivo. Finally, chapter 6 summarizes the major 
contributions of this work and the potential future efforts. 
The second chapter describes the interrogation module for actuation and verification of the 
actuation of magnetoelastic actuators integrated onto a glaucoma valve.  The vibration of the 
excited actuator is intended to reduce the cell adhesion and fibrous capsule formation, improving 
the efficacy of these valves.  This interrogation module also includes sensing for verification of 
actuation to ensure that the actuator is functional over the implant period.  A physical domain 
decoupling approach is implemented in this module.  A series of DSP techniques are implemented 
for improving the SNR and wireless range.  This chapter discusses the benchtop experiments with 
the actuator using the developed interrogation module.  Finally, this chapter discusses the in situ 
and in vivo experiments conducted. 
The third chapter details the miniaturized self-biased sensor design, and fabrication 
methods.  The sensor structure is a rectangular beam with two mass loads, one on each longitudinal 
end. These mass loads act as magnets to bias the sensor as well as help in preserving a low resonant 
frequency.  The sensor is fabricated using microfabrication tools, including micro-electro-
discharge machining, and the mass loads are attached at the longitudinal ends using a transient 
liquid phase bond.  This chapter also includes the in vitro experiments performed, mimicking the 
sludge accumulation and sensor sensitivity results. 
The fourth chapter discusses the design and fabrication of hybrid packages for protecting 
the magnetoelastic sensors for biliary stent monitoring.  The hybrid package presented here is a 
polymer structure reinforced by highly elastic Nitinol wires to strike a balance between the 
required elasticity and stiffness for successful endoscopic deployment. Bending tests were carried 
out to ensure that this hybrid package is able to tackle the mechanical challenges of delivery and 
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deployment. This chapter also discusses the effect of the packaged sensor itself on the occlusion 
dynamics. Finally, In vitro tests, including culturing of bacteria in bile and flowing the mixture 
through both package-instrumented stents and normal stents, were carried out to evaluate the effect 
of the package on occlusion dynamics. 
The fifth chapter describes the implementation of an interrogation module for the biliary 
stent monitoring system.  This interrogation module works on time domain decoupling approach 
to minimize the signal feedthrough and careful hardware implementation for improving the 
wireless range.  Several digital signal processing techniques are also used to improve the signal to 
noise ratio.  Finally, this chapter also discusses the successful in vivo experiments with a porcine 
subject for a demonstration of the complete biliary stent monitoring system. Finally, chapter 6 
summarizes the performance of these two magnetoelastic systems and discusses the major 







2 Chapter 2: Magnetoelastic System for Mitigation of  
Glaucoma Valve Encapsulation 
2.1 Introduction 
 In this chapter, a magnetoelastic system for use in glaucoma valve encapsulation mitigation 
is discussed, particularly concerning the development and characterization of an appropriate 
interrogation module.  As described in Chapter 1, a magnetoelastic actuator can be integrated onto 
the glaucoma valve, and the vibration of the actuator at resonance can agitate the liquid around it 
and potentially mitigate the onset or acceleration of fibrous encapsulation of the valve.  The system 
level challenges in this application include (i) the fabrication of magnetoelastic actuators and their 
integration onto an AGV, and (ii) the challenges associated with the interrogation module 
including signal feedthrough, wireless range, and clinical utility.  These challenges are addressed 
in this work.   
 The following sections focus on the approaches used to overcome these challenges and 
experimental demonstrations of the system.  First, the challenges with respect to the actuator 
fabrication and integration onto the AGV are discussed.  Subsequently, the benchtop experimental 
results of an interrogation module using a laser displacement sensor are presented.  Challenges 
with this module are addressed by an acoustomagnetic interrogation module which utilizes a 
hydrophone; the concept and design for this module are presented.  The benchtop, in vitro, and in 
situ experimental results with this acoustomagnetic module are then discussed.  Further, a 
simplified interrogation module is developed for in vivo experiments, and the in vivo experiments 
with this simplified module are detailed, followed by conclusions. 
21 
 
2.2 Fabrication of magnetoelastic actuator and integration onto the AGV 
The challenges associated with the magnetoelastic actuator for glaucoma valve 
encapsulation mitigation include its fabrication, corrosion protection of the actuator – since the 
valve is in a liquid environment – and finally, the integration of the actuator onto the AGV.  The 
magnetoelastic actuator for this application must be a three-dimensional structure so that it can be 
conformally be integrated on to the curved surface of the AGV. A three-dimensional aspherical 
structure also allows for out of plane vibrations that can agitate the liquid around. First, the 
actuators are fabricated from 28 µm thick Ni/Fe foil (MetglasTM 2826MB) using photochemical 
machining.  These fabricated actuators are planar and were sandwiched between the Cobalt-
Chrome alloy molds of exaggerated curvatures and annealed at 275ºC for 12 hours.  These curved 
actuators can then conform to the curved surface of the AGV.  This fabrication procedure is 
adapted from previous work [Pep15b].   
The actuator has several structural features – including paddles, anchors, and springs – 
which allow the actuator to vibrate effectively to agitate the surrounding fluid.  The paddles are 
specifically for moving the liquid around, while the springs help to enable out of plane vibration 
and reduce losses through the valve substrate.  Two designs are used in this work; Type I has 
paddles with a joint, whereas Type II has continuous paddles, as shown in Fig 2.1.  Experiments 
have demonstrated that both of these designs can agitate the liquid around it; only the mode shapes 
differ [Pep15b].  The schematics of these two types of actuators are shown in Figure 2.1. The 




Fig. 2.1: Schematic of Type I and Type II actuators [Pep15b]. 
The specific challenges addressed in this work are corrosion in the liquid medium and valve 
mounting issues.  A 100 nm-thick aluminum oxide is coated onto these actuators using atomic 
layer deposition (ALD) in order to provide biocompatibility and to prevent corrosion.  
Experimental results showing the efficacy of this approach are presented in a later section of this 
chapter.  The actuator is a metal alloy, and the AGV is made of silicone rubber.  This poses a 
challenge in attaching the actuator onto the AGV, due to its deformability and relatively low 
surface energy.  Several experiments were conducted with various biocompatible epoxies, and 
NuSil epoxy (Med3-4213) was found to be effective and was used to bond the actuator onto the 
AGV.  This is a two-part epoxy which is biocompatible, and a two-part side-by-side kit adapter 
and mix tip are used to prepare the epoxy in a 1:1 ratio.  The epoxy is applied to cover the entire 





Fig. 2.2: Photograph and schematic of the application of NuSil epoxy onto the actuator. 
The bond is then cured in an oven at 100ºC for 30 mins and cured further for 12 hours at room 
temperature.  The bond was strong enough that the separation force applied deformed the actuator 
before breaking the bond apart.  Type I and Type II actuators mounted on AGVs using this 
technique are shown in Fig. 2.3. 
 
Fig. 2.3: Actuators mounted on AGVs. (a) Type I; (b) Type II. 
2.3 Interrogation using a Laser Displacement Sensor 
 This section describes the development of an interrogation module for the magnetoelastic 
actuators for glaucoma valve encapsulation mitigation using a laser displacement sensor.  The 
actuators need to be excited, but also the interrogation must include a detection mechanism for the 
verification of actuation. Confirmation of actuation is required to ensure that the actuator is 
operational after the implantation as the tissue heals and grows.  Experiments demonstrating that 
actuation can be measured with this set-up when the actuator is in water and under the conjunctiva 
24 
 
simulant layer were conducted.  The experimental set-up developed toward this goal is shown in 
Fig. 2.4.   
 
Fig. 2.4: Interrogation module using a laser displacement sensor for exciting the actuator as well 
as for the verification of actuation. 
 This interrogation module consists of an inductive transmit coil for actuation, a laser 
displacement sensor for sensing the vibration and several hardware components. In this module, 
the required AC magnetic field is generated via inductive transmit coils and DC bias by a 
commercial Helmholtz coil system.  The transmit coils consist of two coils in parallel with each 
having 100 turns.  The function generator (Agilent 33220A) generates the required sine wave and 
is programmed by the PC using GPIB-USB-HS cable (National Instruments).  The buffer circuit 
(with a buffer amplifier) and metal oxide varistor (MOV) (More details on this is in Chapter 6) is 
for protecting the function generator from any fly-back voltage from inductive coils.  For the 
verification of actuation, a laser displacement sensor (Model LK-G32, Keyence) (LDS) is used. 
The laser is pointed onto the paddle of the actuator for displacement measurements.  As the 
actuator vibrates, the LDS senses the displacement of the paddle, and this data is collected to the 
PC using a data acquisition device (National Instruments DAQmx).   
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A series of signal processing techniques were implemented in LabVIEW to improve the 
SNR and subsequently, the wireless range.  Filters were optimized, and group delay (GD) 
compensation was implemented in order to efficiently recover the signal.  The details of the signal 
processing techniques are discussed later in this chapter. With this set-up, actuation was measured 
in water and under conjunctiva simulant (a silicone contact lens draped over the actuator), and 
results are illustrated in Fig. 2.5.  For these experiments, the actuators were mounted onto metal 
plates rather than onto a real AGV. 
  
Fig. 2.5: Frequency response from the actuator Type I in water (left), in water with conjunctiva 
simulant (right). 
 
This interrogation module developed using an LDS for detection of the vibration of the 
actuator could successfully excite the actuator and detect the actuator vibrations indicating the 
actuator functionality.  Fig. 2.5 shows that the actuator resonance occurs at ~480 Hz.  Although 
the signal reduced and the resonant frequency shifted lower after introducing the conjunctiva 




2.4 Acoustomagnetic interrogation module 
 The interrogation module using LDS posed several drawbacks which led to the 
development and interrogation module using a hydrophone. Although the vibration of the actuator 
was successfully verified using the interrogation module with LDS, the SNR in the case with a 
conjunctiva simulant was weak.  Moreover, this method requires precise positioning of the laser 
onto the actuator, and the laser may be obscured or scattered by tissue overlying the actuator.  A 
laser detection method also has a potential blinding hazard associated with it.  In contrast, an 
alternate approach using a hydrophone may be less sensitive to precise positioning and eye 
movement and is investigated.  This approach is similar to the ophthalmologic B-scan 
ultrasonography, indicating clinical utility.  The actuator is excited magnetically, and the acoustic 
response from the vibrating actuator is detected in this module. This physical domain decoupling 
eliminates the issue of the signal feedthrough. Various signal processing techniques are also 
implemented to improve the SNR and thus wireless range. The schematic of the interrogation 
module is illustrated in Fig. 2.6. 
 
Fig. 2.6: Interrogation module using hydrophone for glaucoma valve encapsulation mitigation 
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 The interrogation system consists of several hardware for the excitation of the actuator and 
detection of the signals generated by the actuator. A signal generator (Keysight 33220A) along 
with a power amplifier (Krohn-Hite 7500) is used to generate the required voltage at the frequency 
necessary.  This voltage is applied across the AC actuation coils (inductive coil) which in turn 
produce the AC magnetic field (≈4 kA/m) that excites the actuator.  A neodymium disk magnet is 
used for providing the required DC bias (40-55 kA/m).  This disk magnet is attached to an 
adjustable piston which can be used to adjust the distance from the actuator to optimize the DC 
bias magnetic field.  A commercially available hydrophone (Aquarian-H3) is used for sensing 
acoustic signals generated by the actuator vibration.   An audio preamplifier (PA-4 Hydrophone 
Preamplifier) is used to amplify the acoustic signal received by the hydrophone with a gain of 12 
dB.  The hydrophone and preamplifier convert the acoustic pressure to a voltage signal, and this 
signal is then collected by a data acquisition device (NI-DAQmx) and sent to a PC for processing 
and display.   The actuator excitation and data acquisition are synchronized by programming in 
LabVIEWTM.  Details of these hardware components, along with digital signal processing, are 
discussed in the following sections. 
Transmit coils: The transmit coils are designed and fabricated to maximize the excitation 
magnetic field for maximum actuator vibrations. The output impedance of the power amplifier is 
200 Ω, and for obtaining the highest magnetic field intensity, the impedance of the coil is matched 
to this value.  The optimized number of turns for maximizing the output is found to be 220.  So, 
the actuation coil is fabricated by winding 220 turns (motor winding wire, 28 AWG) on a PVC 
pipe with a 24 mm radius.  
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Signal generator and the amplifier: The signal generator and the power amplifier are used 
to generate the sinusoidal voltage across the transmit voltage.  The sine signal generated by the 
signal generated is amplified by the power amplifier for increasing the excitation field. 
Hydrophone, audio preamplifier and data acquisition device:  The hydrophone and 
preamplifier are used in the actuator signal detection for sensing the acoustic signals generated by 
the vibrating actuator and then convert to voltage signals.  The data acquisition device then records 
these voltage signals for process and display. The hydrophone is sensitive to acoustic pressure 
generated by the movement of the actuator, transmitted through the intervening tissue and fluids.  
The hydrophone is specified as having a sensitivity of -192 dB re: 1 V/µPa. For reducing acoustic 
attenuation at tissue/air interfaces, the hydrophone is custom-packaged in ultrasound gel, as shown 
in Fig. 2.7.  The hydrophone is packaged inside a PVC tube filling the sensor area in ultrasound 
gel. A thin, one-side-cementable 60 µm FEP film is used to close the side that is facing the actuator. 
The thin film will ensure low attenuation at this boundary.  Finally, the voltage signals amplified 
by the audio preamplifier is recorded to a PC using a data acquisition device. 
     
 
Fig. 2.7: Custom packaged hydrophone for minimizing acoustic attenuation. 
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 Digital signal processing: Although the acoustic signal received by the hydrophone is 
amplified using the preamplifier, the signal is still noisy.  As such, a series of digital signal 
processing techniques are implemented to improve the SNR and thus the wireless range.  The flow 
diagram of the signal processing steps in LabVIEW is shown in Fig. 2.8. 
 
Fig. 2.8:  Digital signal processing flow implemented in LabVIEWTM. 
The acquired signal is first filtered using a moving bandpass filter to remove the higher and 
lower frequency noise.  This filter is a narrow bandpass filter centered at the actuation frequency, 
which  is swept.  The filtered signal is then quadrature mixed to isolate the essential frequency 
component.  The magnitude calculation and the low pass filter are then used to extract the envelope 
of the amplitude of the signal.  The signal amplitude is integrated over time to leverage the full 
signal response energy. The measured E (cumulative power) is defined as: 
𝐸𝐸 = ∑ 𝑥𝑥𝑛𝑛21000𝑛𝑛=0                                                                  (2.1)                    
where xn is the amplitude of the signal at sample n after digital signal processing.  The reference 
signal in these plots is the signal measured when the actuator was absent. The actuation frequency 
is swept while monitoring the acoustic response, which is expected to peak at resonance 
frequencies of the actuator. All these processes are programmed using a LabVIEW code. 
2.5 Benchtop Experiments 
 Several benchtop experiments were conducted in order to evaluate the performance of the 
interrogation module developed as well as to investigate the challenges related to integrating the 
actuator onto the valve and corrosion protection.  Previously, the actuator response was detected 
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while mounted on a metal plate [Pep15b].  So, experiments were conducted to see if the actuator 
response attenuates when mounted onto a valve-like substrate.  The AGV is implanted inside the 
eye above the scleral tissue but under the conjunctiva layer. So, experiments were conducted to 
see if the actuator signal attenuates in the presence of the conjunctiva layer. Finally, experiments 
were performed involving corrosion protection techniques using an aluminum oxide coating. 
These experiments are detailed in the following sections. 
PDMS Mold Experiments: Previous experiments were conducted mounting the actuator 
onto metal plates. So, initial investigations were focused on making sure the actuator behaves 
similarly when mounting to a real AGV instead of metal plates.  An AGV is made of silicone 
rubber. Hence a similar material, Polydimethylsiloxane (PDMS), was chosen to mimic the 
properties.  A PDMS mount with similar curvature to that of the real valve is fabricated. For this, 
the annealing plates that were used for curving the actuator are used as the mold. These plates were 
cleaned with acetone, isopropyl alcohol, and DI water.   PDMS (Dow Corning Sylgard 184) was 
prepared at 10:1 ratio and filled in the mold, as shown in Fig 2.9 (left). Scotch tape was placed 
around the open edges of the metal plates to keep the PDMS inside the mold. PDMS was then 
cured at 120ºC for 30 minutes. Annealing plates were separated (peeled off) using a tweezer.  The 
fabricated PDMS mount is shown in Fig. 2.9 (right). 
  
Fig. 2.9: Schematic of mold created using annealing plates filled with PDMS, and photograph of 




The thickness of this mold was measured and found to be 1.56 mm.  (A typical valve thickness 
varies between 1.1 mm to 1.84 mm.)  A Type I actuator was mounted onto this, as shown in Fig. 
2.9 (right).  The frequency response from the experiments is illustrated in Fig. 2.10.  The DC bias 
(30 G) in this experiment was applied using Helmholtz coils instead of a permanent magnet. 
 
Fig. 2.10: Frequency response while the actuator is mounted onto a metal plate and onto the PDMS 
mount. “Ref. signal” is the signal when no actuator is present (i.e., background noise). 
The signal strength is reduced to 30% in the case of PDMS substrate used instead of an actuator 
mounted on a metal plate. This is attributed to the change in acoustic impedance due to the 
difference in the mounting substrate.  However, the functionality of the actuator could be verified 
with an SNR of ≈28. 
Conjunctiva simulant experiments: In the intended application, the actuator integrated 
valve is implanted above the sclera and under the conjunctiva layer.  In the next step, tests were 
conducted to see if the presence of a conjunctiva simulant affects the actuator response.  The 
conjunctiva simulant (contact lens), is placed over the actuator, as shown in Fig. 2.11 (top).  The 
actuator was mounted on a metal plate for this experiment.  Type I and Type II actuators were used 
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for these experiments.  The DC bias applied was 47 G for Type I and 40 G for Type II.  The 
frequency response in these cases is shown in Fig. 2.11.  
 
Fig. 2.11: : Schematic showing placement of conjunctiva simulant over the actuator (Top). 
Frequency response from the actuators in cases with and without conjunctiva simulant. Type I, 
Type II (right). The traces labeled “w/o conjunctiva” are signals without the contact lens. The 
traces labeled “w/ conjunctiva” are signals with the conjunctiva simulant. “Ref. signal” is the 
signal when no actuator is present (i.e. background noise).  
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The signal strength in various cases is reduced by ≈50% -80% for both the actuators while the 
conjunctiva simulant is present.  However, the signal strength was sufficient, with an SNR ≈12, to 
confirm that the actuator is functional. 
Corrosion prevention experiments: The actuator will be in a liquid medium – aqueous 
humor and other biological fluids – after implantation. Thus, there is a possibility of 
corrosion/rusting of the actuator after implantation. Experiments were conducted to assess the 
prevention of corrosion by coating with aluminum oxide. The thickness of aluminum oxide must 
be determined. Two samples were coated, one with a 10 nm thick layer and the other with a 100 
nm thick layer. The actuator with 10 nm thick coating was immersed in DI water while the one 
with 100 nm thick coating was immersed in brine solution (prepared with dissolving 0.37 g of 
calcium chloride and 0.37 g of sodium chloride (2%) in 17.36 g of water). Rusting was observed 
in the case of the actuator which was placed in DI water after one week. Also, the actuator did not 
produce any measurable signal while interrogated. A photograph of the actuator and the schematic 
showing the rusted area are shown in Fig. 2.12. 
 
Fig. 2.12: Visuals of the rusted actuator, highlighting the middle spring where the rusting is 
suspected to have started. 
For the actuator with 100 nm alumina coating and immersed in brine, some rusting was observed 
after 20 days, but the actuator still provided a good signal.  A photograph of the actuator is shown 
in Fig. 2.13 (inset). The frequency response before and after rusting is shown in Fig. 2.13. Although 
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the signal is reduced by 40%, it is concluded that 100 nm aluminum oxide coating is sufficient to 
keep the actuator from extreme rusting and to maintain functionality. 
 
      
Fig. 2.13: Frequency response from the actuator before and after rusting. “Ref. Sig.” is the signal 
when the actuator is absent. Rusted actuator after immersing in brine for 20 days (inset). 
 
2.6 In vitro Experiments 
In vitro experiments were conducted to demonstrate the magnetoelastic system and 
evaluate the performance of the interrogation module developed in this work.  These experiments 
were conducted by immersing the actuator integrated AGVs in water, as shown in Fig. 2.14. 
 
Fig. 2.14: Schematic of the in vitro experimental setup. 
The actuator integrated AGV was immersed in water while the custom-packaged hydrophone was 
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positioned close (≈1 mm) to the actuator. The front surface of the package was submerged in water 
so that there was no intervening air in the path of the acoustic signal generated by the actuator.  
The excitation coil (AC coil) was ≈32 mm away from the actuator, and the neodymium disk 
magnet was positioned ≈42 mm away from the actuator.  The frequency responses measured using 
this setup are shown in Fig. 2.15.   
 
Fig. 2.15: In vitro frequency response of the actuators. Type I (left); Type II (right). The reference 
signal in these plots is the signal measured when the actuator was absent. 
 The resonant frequency of the Type I actuator was found to be ≈3.2 kHz while that of Type 
II was ≈4.2 kHz. The signal strength in terms of summed squared signal amplitude was ≈140 for 
Type I while that of Type II was ≈110. The maximum pressure amplitude in vitro estimated using 
experimental results is ≈140 Pa.  The generated acoustic pressure can be estimated assuming the 
actuator to be a circular piston [Pie89]: 
)()( 0
jkrjkz eecvzp −= ρ                                                    (2.2) 
where acoustic propagation: p is the pressure generated by vibrating circular piston, z is the 
distance from the piston (0 m for calculating maximum pressure), c is the velocity of sound in 
water (1500 m/s), ρ0 is the density of water (1000 kg/m3), v is the maximum velocity of the actuator 
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surface (150 µm/s), k is the propagation constant (2πf/c), f is the vibration frequency, and r is the 
distance from the edge of the piston to z (5 mm).  With a vibration frequency of 4 kHz and the 
values listed above, Eq. (2.2) estimates a maximum acoustic pressure of 225 Pa.  This agrees with 
the estimated experimental value of ≈140 Pa. Successful verification of actuation indicated that 
the system is ready to test in situ.  
2.7 In situ experiments 
 The in situ experiments were conducted to demonstrate the functionality of the system in 
an implanted environment.  These experiments investigated to evaluate the factors like the 
presence of tissue in an implanted environment that could affect the performance of the system.  
These tests used eyes that were harvested from deceased porcine specimens.  The size and shape 
of a porcine eye are similar to that of a human eye, and also the conjunctiva and scleral tissue are 
similar in composition to that of a human eye.   
 The surgical procedure for the implantation was as follows. Using Westcott scissors and 
forceps, a conjunctival incision was made at the limbus.  Blunt dissection was carried out to 
separate the overlying conjunctiva from the underlying sclera.  The AGV was primed using a 
balanced salt solution.  Using a Nugent forceps, the AGV was positioned between the conjunctiva 
and sclera and sutured to the sclera 8 mm posterior to the limbus using 7-0 polyglactin suture.  The 
tube of the implant was trimmed and inserted through a sclerotomy into the anterior chamber of 
the eye.  The tube was secured to the globe using a 9-0 nylon suture.  A paracentesis was created 
to reflate the chamber during the testing.  The overlying conjunctival tissue was reapproximated 
using an 8-0 polyglactin suture.  After the AGV was attached to the globe, the fluid flowed through 
the tube forming a reservoir around the device. Visuals of the implantation in progress and the 





Fig. 2.16: AGV implantation in progress (Top). Implanted actuator and valve covered by 
conjunctiva (bottom). 
The Type I actuator was measured with the conjunctiva layer in place (Fig. 2.16 (bottom)).  For 
expediency, the Type II actuator was measured with connective tissue draped over the valve.  Fig. 
2.17 shows typical measurements from the implanted actuators using the interrogation module.   
  
Fig. 2.17: Post-implantation frequency response of the actuators. Type I (left); Type II (right). The 
reference signal in these plots is the signal measured using the interrogation module on an eye 




The resonant frequency of Type I is 4.5 kHz, and Type II is 3.8 kHz; the SNR is 3 to 6 with a 
quality factor of ≈10. Compared to the in vitro response of the actuators shown in Fig. 2.15, the 
signal from the actuator after implantation is attenuated as well as shifted.  The resonant frequency 
of Type I is shifted by ≈1.4 kHz while that of Type II is shifted by ≈600 Hz.  The summed square 
signal amplitude dropped by ≈120 a.u in the case of Type I and ≈96 a.u. in the case of Type II. 
Successful signal detection from the actuator indicates that the actuator is functional after 
implantation.  These acoustic signals measured are first acoustic signatures measured from an 
implanted magnetoelastic device. 
2.8 In vivo experiments  
 In vivo experiments were conducted to demonstrate the functionality of the magnetoelastic 
system in a live animal.  Successful in vivo experiments will indicate the readiness of the system 
for clinical trials in the future.  The in situ experiments indicated that the frequency shift after 
implantation is not significant, a simple patient-friendly interrogation module consisting of only 
the actuation module without feedback is developed for the in vivo experiments.  Also, having an 
interrogation module in a closed loop with hydrophone sensing and multiple hardware components 
is difficult to be implemented in an in vivo scenario.  As such, the interrogation module was 
simplified to just an actuation module without measurement of response or feedback.  First, the 
development of this simplified actuation module is detailed, followed by the in vivo experiments 
performed with it. 
Simplified actuation module: As described before the interrogation module is simplified to 
an actuation module for in vivo experiments.  This module is developed focusing on the clinical 
utility to easily implement on a live subject by clinicians under minimal instructions.  In this 
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module, the actuator is subjected to a wide range of frequencies which include the resonant 
frequency of the actuator.  Using a range of frequencies, in the form of a slowly swept signal, 
ensures that the actuator will be excited even if its resonant frequency is shifted after implantation.  
The schematic of the simplified actuation module is shown in Fig. 2.18. 
 
Fig. 2.18: Schematic of a simplified actuation module for in vivo experiments. 
This module consists of an audio amplifier that can generate sinusoid voltage signals across 
inductive coils which in turn will generate the excitation magnetic field.  The audio amplifier is 
controlled by an audio file that contains an audio signal with the frequency of from 2 kHz to 8 kHz 
since the resonant frequency of actuators is, in general, in this range.  A chirp .mp3 file from 2 
kHz to 8 kHz was made using AudacityTM, and this chirp has 0.2 amplitude at 2 kHz, and this 
increases linearly with frequency and finally has amplitude 1 at 8 kHz.  This linear variation of 
amplitude with frequency ensures that the current through the coil (and thus the excitation 
magnetic field) is kept similar for all the frequencies in this frequency range.  The sweep takes 30 
seconds to complete and can be repeated for more extended excitation sessions.  The audio 
amplifier (Pyle Home PT270AIU 300-Watt) is used to convert this audio file into corresponding 
voltage signals. This amplifier has four terminals with the specified ideal load impedance of 8 Ω 
for each. It was experimentally found that ~55 turns coil results in the impedance of 8 Ω in this 
frequency range. For maximizing the magnetic excitation, four coils are connected to the four 
terminals of the amplifier, with all coils wound coaxially to superpose the field generated by each.   
 Considering the clinical utility of the system, it is desirable to have the coil fabricated onto 
a wand-like structure with handle and with a provision for adjusting the DC bias in order to have 
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ease of implementation in live animal tests. So, a wand-like structure was modeled and fabricated 
with a 3D printer (Dimension Elite) out of acrylonitrile butadiene styrene (ABS) plastic. The 3D 
model of the coil/magnet wand structure is shown in Fig. 2.19. 
 
Fig. 2.19: 3D model of the different parts of the coil/magnet wand. 
 The coil/magnet wand has three parts.  Part A consists of the basic structure with a specific 
slot for winding the AC actuation coils and a handle to hold during in vivo experiments.  Part A 
also has a through-hole channel to route out the terminals of the four AC coils to an eight-terminal 
connector.  Part B is where the array of neodymium magnets is placed for providing the required 
DC bias.  Part B is attached to part A via the thread system so that the distance of this magnet array 
from the actuator can be adjusted in order to change the DC bias as necessary for different 
implantation depths.  Finally, part C is acting as a lid to the part B assembly to keep the array of 




Fig. 2.20: Detailed description of part A of the wand and the dimensions. 
 
The four 50 turns coils (56 mm diameter, 20 mm length) were wound, co-axial, each wrapped in 
consecutive layers as uniformly as possible in the specified slot in the part A of the coil/magnet 
wand. The array of disk magnets were also inserted in the corresponding slots with the help of part 
B and part C. 
In vivo experiments:  In vivo experiments were conducted on live rabbits (New Zealand 
Rabbit) using the interrogation module developed.  The eye size and the composition of the eye of 
these rabbits are similar to that of humans and hence chosen as subjects for live animal tests.  In 
vivo experiments consist of the surgical procedure for implantation of the actuator integrated AGV, 
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the actuation session with the simplified actuation module and finally the postmortem of the 
subjects.  These steps are detailed in the following sections. 
Implantation surgery: The actuator integrated valves were implanted by Dr. Ying Han and 
Dr. Behzad Amoozgar (University of California, San Fransisco). Surgical procedures started by 
sanitizing the actuators by spraying with isopropyl alcohol (IPA) and exposing them to ultraviolet 
(UV) radiation.  Epinephrine was injected into the subjects 30 mins before surgical procedures.  
The intraocular pressure was measured using Tonovet (Icare).  The animals were premedicated 
with subcutaneous injection of buprenorphine by the veterinary staff to provide pre-emptive 
analgesia. An injectable combination of ketamine and xylazine were administered 
intramuscularly; then mask anesthesia delivery of isoflurane was applied initially to get the rabbits 
sufficiently anesthetized, as indicated by lack of muscle tone and loss of gag reflex; the 
endotracheal tube was then placed by the veterinary staff using standard insertion technique.  In 
order to maintain normovolemia, an intravenous catheter was placed in the rabbit’s marginal ear 
vein to deliver intravenous fluids during anesthesia.  After adequate anesthesia was achieved, the 
right eye of each rabbit was prepared with povidone-iodine.  A lid speculum was placed.  A 9-0 
Vicryl suture was passed through the superotemporal limbus to rotate the eye downward.  
Conjunctival peritomy was performed at the limbus in the superotemporal quadrant, followed by 
posterior dissection in the same plane.  The actuator integrated valve was placed via micro-forceps 
on the episcleral surface approximately 6 mm from the limbus.  A paracentesis was created via a 
supersharp blade.  Viscoelastic was injected into the anterior chamber.  The 23G needle was used 
to create an entry at 2 mm from the limbus into the anterior chamber.  The tube of the AGV was 
inserted into the anterior chamber via the same track. The tube was handled with care in order to 
not make contact with the cornea and thus minimize irritation.  The conjunctiva was closed to the 
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limbus with interrupted 8-0 vicryl sutures.  At the end of the surgeries, 150 µL of cefazolin was 
injected subconjunctivally for antimicrobial prophylaxis.  The catheter was removed, and 
hemostasis was achieved by direct pressure over the insertion site.  Post-operative treatments were 
included antibiotics with predforte for the first five days, three times per day (including surgery 
day).  During the second five days predforte was used only twice daily, and in the third five days 
predforte was used once daily. The visual of the surgery in progress is shown in Fig. 2.21. 
 
Fig. 2.21: Implantation of magnetoelastic actuator integrated AGV in rabbit T1438. Surgery in 
progress. 
Actuation Sessions: Actuation sessions were carried using the simplified actuation module 
to excite the implanted actuator.  Actuation was done only for the experimental subject (subject I, 
rabbit T1438).  The rabbit was under isoflurane anesthesia for the duration of the actuation process.  
The coil/magnet wand made of inductive coils and an array of permanent magnets was brought 
close to the animal, against the fur of the animal, ~1.5 cm away from the implanted actuator, near 




Fig. 2.22: Wireless actuation of the implanted actuator using  the coil/magnet wand. 
The wand was placed so that the axis of the coil on the wand is aligned to the implanted actuator 
integrated AGV.  The distance of the magnet array from the AGV was adjusted to be ~5.5 cm.  
The audio file plays for 30 seconds, and then automatically repeated for voltage generation and in 
turn the magnetic field for exciting the actuator.  To verify stable connections, the voltage at the 
four outputs of the amplifier was measured, while the wand was connected, using the portable 
oscilloscope (Picoscope).  For a volume setting of 20 dB, the peak voltage was measured to be 
~200 mV (at ≈7 kHz) from all the terminals and all connections were confirmed to be intact.  For 
actuation purposes, the amplifier volume setting of 50 dB is used, and the AC magnetic field on 
the axis of the wand at the face of the wand was measured using an axial probe and a gaussmeter 
(F.W. Bell Model 5170)  in AC mode. This was found to be ~10 G (800 A/m).  Using these settings 
and based on these measurements, an estimated AC magnetic field of ~400 A/m (at a frequency 
swept from 2 kHz up to 8 kHz), along with a steady magnetic field of up to 4 kA/m, was generated 
at 1.5 cm away from the face of the wand (at the location of the actuator integrated AGV) by the 
coil/magnet wand.  The duration of the actuation was 20 mins and was performed twice a week, 
for 4 weeks postoperatively. The animals were under observation in a housing facility under proper 
45 
 
veterinary care. There was no health illness observed on the subjects during the whole experiment 
until the euthanizing. 
 Postmortem observations: Both the rabbits were euthanized after 4 weeks, and the valves 
along with actuators were explanted.  Explanted valves were then observed under the microscope, 
and there wasn’t any visible sign of corrosion on the actuator. The visuals of the explanted valve 
are shown in Fig. 2.23. and close-up visuals of the actuator parts are shown in Fig. 2.24 and Fig. 
2.25. The actuators were damages during the explanation procedure but not while implanted inside 
the eye.   The bond between the actuator and AGV was intact before explantation, and this indicates 
success in the valve mounting technique introduced in this work.  Photographs of the eyes of the 
subjects after postmortem and pre-enucleation are shown in Fig. 2.26. 
 





Fig. 2.24: The small parts of the actuator which was implanted inside the test rabbit. There is no 
clear sign of corrosion on any of these parts. 
 
 
Fig. 2.25: The small parts of the actuator which was implanted inside the control rabbit. There is 
no clear sign of corrosion on any of these parts. 
 
Fig. 2.26: Visuals of the actuator implanted eye of the test rabbit (left) control rabbit (right) after 
postmortem and pre-enucleation. 
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Both eyes were preserved in formaldehyde 10% for preserving the tissue for histology.  
Preliminary observation on the explanted actuators confirms successful corrosion protection 
techniques of the aluminum oxide coating.  
2.9 Summary and Conclusions 
In this chapter, a magnetoelastic system for glaucoma valve encapsulation mitigation is 
discussed, which consists of an actuator and interrogation module for interacting with the actuator. 
The magnetoelastic actuator was integrated onto an AGV using silicone epoxy, and the actuator 
was also coated with 100 nm aluminum oxide to prevent corrosion and to provide biocompatibility.  
Benchtop experiments were conducted to investigate these techniques followed by in vitro 
experiments. The module developed in this work improved the SNR in vitro by 20x compared to 
previous methods [Pep15b]. Further, the actuator integrated AGV was interrogated in situ in 
porcine eyes. Successful signal detection from the excited actuator confirmed that the actuator is 
functional after implantation inside the eye. These signals from the actuator sensed using the 
hydrophone are the first acoustic signature received from a magnetoelastic actuator through the 
tissue. The interrogation module in the feedback loop was not practical in case of in vivo 
experiments, and hence a simplified actuation module was developed minimizing the module to 
just only actuation without sensing actuator signal. Finally, the actuator integrated AGV was 
surgically implanted in live rabbit subjects. The simplified actuation module is used to excite the 
actuator implanted. Preliminary observations showed that the aluminum oxide coating helped in 
preventing the corrosion and the valve mounting technique introduced in this work is observed to 
be successful. Also, the in vivo results presented indicate that the implanted actuator does not 





3 Chapter 3: Sensor Design and Fabrication for Biliary Stent Monitoring 
3.1 Introduction  
As discussed in the introduction (1.3.2), one of the significant challenges in the implanted 
module for biliary stent monitoring is the miniaturization of the magnetoelastic sensor.  A 
miniaturized sensor is especially desirable for implanted applications because it simplifies the 
implantation procedure, reduces the impact of the implant on the biological systems, and enables 
applications in smaller internal organs.  However, as the sensor size decreases, the signal strength 
decreases drastically while the resonant frequency increases.  This is undesirable, as it limits 
interrogation at larger wireless ranges. Also, the sensor must be biased with a DC field. An efficient 
way to bias as well as preserve the resonant frequency at the same time while miniaturizing is to 
employ targeted mass loading.  The sensor was also coated with a hybrid coating for corrosion 
protection. The schematic of the sensor is shown in Fig. 3.1.   
 
Fig. 3.1: Self-biased mass-loaded magnetoelastic sensor fabricated from Metglas and Arnokrome 
with Au-In transient liquid phase (TLP) bond. 
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This chapter discusses the design and fabrication of the sensor, followed by the benchtop and in 
vitro characterization of the sensor, specifically for the application of biliary stent monitoring. 
 
3.2 Design and Fabrication  
The sensor has two magnetic mass loads attached at the two longitudinal ends (Fig. 3.1). 
The sensor structure is made of MetglasTM 2826B, and the mass loads are made of ArnokromeTM 
5.  As discussed in the previous section, these magnetic mass loads help to preserve the resonant 
frequency and bias of the sensor. Assuming the longitudinal vibration of a thin uniform beam 
which has material density 𝜌𝜌, and modulus E, the wave equation is [Ros07]: 







                                                               (3.1) 
where = �𝐸𝐸𝜌𝜌 , The complete solution to this wave equation is: 
𝑢𝑢 = (𝐴𝐴sin �ω
c
� 𝑥𝑥 + 𝐵𝐵cos �ω
c
� 𝑥𝑥)(𝐶𝐶sinω𝑡𝑡 + 𝐷𝐷cosω𝑡𝑡)                              (3.2) 
For a free-free beam sensor, the strain ∂𝑢𝑢/ ∂𝑥𝑥 = 0 at  𝑥𝑥 = 0 and 𝑥𝑥 = 𝐿𝐿0. The resonant frequency 




�𝐸𝐸𝜌𝜌𝑠𝑠  (𝑟𝑟𝑟𝑟𝑟𝑟/𝑠𝑠)                                                        (3.3) 
Assuming the mass loaded sensor design to be equivalent to a point-mass load (M) beam, the 
boundary conditions change such that 𝑢𝑢 = 0 at 𝑥𝑥 = 0 and 𝐹𝐹 = 𝑆𝑆𝐸𝐸(∂𝑢𝑢/ ∂𝑥𝑥) = −𝑀𝑀(∂2𝑢𝑢/ ∂𝑡𝑡2) at 
𝑥𝑥 = ± 1
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                                          (3.4) 
For the resonant frequency of the mass loaded sensor and the free-free beam sensor to be equal, 







                                                      (3.5) 
For a design with a 28 μm-thick sensor with 60 μm-thick magnets mass loads, M = 0.473 mg,           
S =0.028 mm2, ρs =7900kg/m3; utilizing (3.5), this requires L0 ≈1.46 L1.  This means that with the 
mass loads at both ends, the beam can vibrate at the same frequency of the free-free structure while 
only occupying 68% of the length. 
The architecture was simulated in a fully-coupled magnetoelastic finite element model 
implemented in COMSOL [Pep15b]. The simulated coil was 5 mm in diameter and 30 mm in 
length, and its surface current density was 22.29 A/m (peak, directed in the azimuthal direction of 
the coil) to provide a 0.28 G AC peak magnetic flux density. The Metglas is only available in 28 
µm-thick foils while Arnokrome is available in 60 µm-thick sheets. As such, a single layer sensor 
(28 µm Metglas) with single layer mass load (60 µm Arnokrome) and a double layer sensor (56 
µm Metglas) with double layer mass loads (120 µm Arnokrome) were simulated. The simulation 
results (Fig. 3.2) indicate that the desired mode of the sensors is at the resonant frequencies of 
180.95 kHz and 182.85 kHz, for a single layer mass load with single layer sensor and double layer 
mass load with a double layer sensor, respectively. The sensor has a small amount of out-of-plane 
displacement even when vibrating in its fundamental longitudinal mode due to the mass loads 




Fig. 3.2: (Left) Simulation of the single layer sensor (30 µm) with a mass-loaded thickness of 60 
µm. The resonant frequency is 180.95 kHz with a maximum mass load displacement of 771 nm. 
(Right) Simulation of the double layer sensor (60 µm) with a mass load thickness of 120 µm. The 
resonant frequency is 182.85 kHz with a maximum mass load displacement of 448 nm.  (Insets) 
Time lapse of the sensor fundamental mode; red to blue represents maximum displacement to zero 
displacement. 
The mass loads in the sensor are intended to be permanent magnets to provide a DC 
magnetic field for biasing the sensor which is required for a large amplitude response from the 
sensor. To estimate the approximate DC magnetic flux density that could be generated in the 
resonator for such an architecture, finite element analysis in COMSOL was utilized. In the 
COMSOL simulations, the magnets have a thickness of 120 μm or 60 μm and are set to have a 
residual flux density of 0.9356 T (along the longitudinal axis of the resonator) and a relative 
permeability of 23. These are the approximate properties of the Arnokrome 5 material. The non-
linear magnetization saturation behavior of the magnetoelastic material was considered in the 
model by setting the sensor material B-H curve to have a saturation induction of 0.88 T at 14 A/m 
(50000 DC relative permeability). Including this saturation behavior allows the model to avoid 
unrealistic shunting of the magnetic field through the highly permeable magnetoelastic material 
directly beneath the magnetic mass loads. The simulated magnetic flux density was found to be 
uniform within the active region of the sensor, as shown in Fig. 3.3. The values were 0.56 T and 
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0.41 T for the 60 μm-thick magnets on the 28 μm-thick sensor and 120 μm-thick magnets on the 
56 μm-thick sensor, respectively. The magnetic flux density was 0.88 T (i.e., saturation) for the 
structure with the 120 μm-thick magnets on the 28 μm-thick sensor.  This indicates that the magnet 
mass loads should provide sufficient DC bias to allow a significantly large sensor response. This 
work focuses on a 28 μm-thick sensor with 60 μm-thick magnets mass loads because of the 
simplified assembly process and more robust fabrication yield. 
 
Fig. 3.3: Simulation of magnetic flux densities through Metglas for varying Metglas/Arnokrome 
thicknesses. 
 
The fabrication of the mass loaded sensor is shown in Fig. 3.4. In the first step, both 
Metglas and Arnokrome samples were cleaned using O2 plasma. Then, 0.1 μm Cr and 0.5 μm of 
Au were deposited on the Arnokrome sheet via e-beam evaporation. Then the sheets were micro-
electro-discharge machined (µEDMed) to make a window in the middle. The windowed samples 
were then electroplated with 6 μm In.  Further, 0.1 μm Cr and 0.5 μm of Au were deposited on the 
Metglas foils, and a transient liquid phase bond was formed between the Metglas/Arnokrome 
layers by applying a pressure of 1.3 MPa at 200°C for 30 mins. The bonding pressure was applied 
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by using custom-designed, spring-loaded C-clamps. Two 3” x 1” glass slides were used to 
distribute pressure along the area of the bonding materials uniformly.  A heating ramp rate of 
6.03°C min-1 and a cooling rate of 0.79°C min-1 ensured adequate inter-diffusion and solidification 
of the mixture to form the Au–In bond (Fig. 3.5). Finally, the sensors were µEDMed from the 
bonded layers. 
 
Fig. 3.4: (a) Evaporation of Cr and Au on Arnokrome. (b) Micro-electro-discharge machining 
(µEDM) of the window (c) Electroplating of In (d) Evaporation of Cr and Au on Metglas. (e) 
Transient liquid phase bond at 1 MPa and 200oC for 30 minutes in the vacuum (f) µEDM of 
sensors. 
 
Fig. 3.5: Heating ramp and the cooling ramp for the transient liquid phase bonding process. 
In the final configuration (Fig. 3.1), the sensor between the mass loads is 6.25 mm long,          
1 mm wide, and 28 μm thick. The mass loads are 1 mm × 1 mm × 67.2 μm (including the Au-In 
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bonding layer) while the platforms underneath the mass loads are 1 mm × 1 mm × 28 μm (i.e., the 
total thickness at the mass loads is 95.2 μm).  This results in a total sensor length of 8.5 mm. The 
fabricated sensor is shown in Fig. 3.6. 
  
Fig. 3.6: Fabricated self-biased magnetoelastic sensor.  
3.3 Experimental Results  
Experiments were conducted for characterizing the sensor. First, the sensor was self-biased 
and compared the performance with an external DC bias. Then, the sensor was coated with a hybrid 
coating for corrosion protection, and the sensor performance was characterized. Finally, in vitro, 
experiments were performed to mimic occlusion and sensor performance and sensitivity were 
measured. The interrogation module used to characterize the sensor is shown in Fig. 3.7. The 
module consisted of inductive coils to excite and detect the sensor magnetically and hardware to 
improve the acquired signal strength.  A transmit coil was used to generate the AC magnetic field 
for exciting the sensor, and a receive coil was used to detect the sensor signals.  A function 
generator, in conjunction with a buffer amplifier, was used to drive current through the transmit 
coils. The sensor signal detected by the receive coil was amplified using a low noise amplifier and 
then acquired to a PC using a data acquisition device. A series of digital signal processing 
techniques were also used to improve the signal to noise ratio.  In this work, the coils had a diameter 
of 3.5 cm, and the width of each coil was 2.2 cm.  The transmitting and receiving coils had 10 
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turns each.  Excitation current amplitude was kept at ≈43 mA (peak to peak) across the transmit 
coil. More details of the interrogation module are discussed in chapter 5. 
 
Fig. 3.7: External interrogation module used for characterizing the sensor. 
a. Self-biasing  
The fabricated sensor was first tested using Helmholtz coils to provide an adjustable DC 
bias and find the largest signal at the optimal bias point.  In subsequent tests, the sensors were 
biased by the mass loads after magnetizing. The resonant response in each situation is shown in 
Fig. 3.8.  When biasing with the Helmholtz coils with a 796 A/m field strength, the resonant 
frequency, normalized signal strength, and quality factor were 185.4 kHz, 4.4, and 412, 
respectively. The magnets were then magnetized using an impulse magnetizer (10 kG peak 
magnetic flux density). The self-biased sensor was tested and found to have a resonant frequency, 
normalized signal strength, and quality factor of 183.8 kHz, 3.4, and 229, respectively. Therefore, 




Fig. 3.8: Sensor response biased with Helmholtz coils and self-biased (magnetizing the mass loads 
on the sensor). 
b. Corrosion Protection 
The sensor must be protected from corrosion due to exposure to the environment. 
Especially for implanted applications, the sensor must also be biocompatible. An aluminum oxide 
coating can be used for these purposes [Gre09a].  The resonant response of the magnetoelastic 
sensor after aluminum oxide coating (100 nm) is shown in Fig. 3.8. Compared to the performance 
of the uncoated sensor, the sensor performance is improved after coating. The coated sensor had a 
resonant frequency of 185.5 kHz with a quality factor of 463 and a normalized strength of ≈19.5 
while the uncoated sensor had a resonant frequency of 183.8 kHz with a quality factor of 229 and 
normalized strength of ≈3.5.   
After aluminum oxide coating, the sensor was then immersed in reconstituted ox bile and 





Fig. 3.9: Photographs of the rusted sensor that is only coated with aluminum oxide. 
As such, an improved hybrid coating approach was investigated.  Parylene is a biocompatible 
material and has also been used to coat sensors for corrosion protection and to ensure 
biocompatibility.  However, Parylene coating has been found to decrease the signal strength to 
20% of the uncoated signal strength after coating [Gre09b].  Thus, a hybrid coating of Aluminum 
oxide and Parylene is used here to provide biocompatibility and corrosion resistance while also 
preserving the sensor performance. The sensor response measured after the hybrid coating 
(Parylene 2 µm and Al2O3 100 nm) is shown in Fig. 3.10.  
 





The hybrid coated sensor has a resonant frequency of 184.5 kHz with a quality factor of 409 and 
a normalized strength of ≈4.5.  This hybrid coating was found to protect the sensor while immersed 
in reconstituted ox bile for at least 7 days. The photographs of the sensor before exposure to bile 
and after 7 days of exposure are shown in Fig. 3.11. 
 
Fig. 3.11: Photographs of the hybrid-coated sensor before (above) and after (below) exposing to 
bile solution for seven days. 
However, longer exposure to the bile deteriorated the sensor performance. The quality factor was 
found to be decreasing, resonant frequency shifting to lower frequencies and signal strength 
decreasing drastically. The sensor performance with respect to these parameters is plotted in Fig. 






Fig. 3.12: Normalized signal strength (left top), resonant frequency (right top), and quality factor 
(bottom) of the sensor immersed in bile over several days. 
c. In vitro Loading 
In vitro experiments were performed to evaluate the sensitivity of the sensor with respect 
to sludge accumulation inside a plastic biliary stent. The sensor was first placed inside a stent piece 
(1.5 cm) and both “caged” in place and protected by a custom 3D-printed polymeric package that 
was stitched into the stent (this package is discussed in detail in Chapter 4).  The synthetic sludge 
was prepared by mixing 1 g of cellulose fiber (90 µm-long, Acros Organics) and 1 g gelatin 
(Kroger) in 10 mL DI water.  The mixture was then injected into the instrumented stent using a 
syringe and then allowed to cure for 20 minutes at room temperature. This cured mixture has 
mechanical properties similar to that of bacteria-generated sludge [Sur18]. The “partial occlusion” 
cases are created by mechanically partially cleaning the fully occluded instrument stent. “No 
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occlusion” cases were mimicked by thoroughly cleaning the instrumented stent with warm water. 
The method used to indirectly quantify the occlusion in a stent is to measure the flow rate of water 
(at 0.5” height) through the stent. By tracking the time and quantity of water collected, the flow 
rate was calculated. Collection time was kept constant at ≈10 seconds, but in some cases of very 
low flow rate, the collection time was extended to ≈30 seconds. 
The instrumented stent was immersed in water while measuring the sensor response. The 
normalized signal strength, resonant frequency, and quality factor of the sensor were measured 
before the flow rate measurement for all the cases. This process was repeated for the same sensor 
8 times. The results are tabulated in Table 3.1.  The typical sensor responses when the stent is 
under full/partial/no occlusion cases are shown in Fig. 3.13.  The photograph of the instrumented 
stent fully occluded using the synthetic sludge is shown in Fig. 3.13 inset. The sensor is buried 
under the synthetic sludge. The normalized signal strength, resonant frequency, and quality factor 
of the sensor with respect to the flow rate through the stent for all the cases are plotted in Fig. 3.14 
and Fig 3.15. 
 
Fig. 3.13: Sensor response when the stent is with no occlusion (V =36.65 mL/min, fr =182.61 kHz, 
Q =94),partial occlusion (V =13.5 mL/min, fr =182.99 kHz, Q =68), and full occlusion (V =0 




Table 3.1: Flow rate measurements and sensor response. 










0 0.135 182.74 65.08 
0 0.869 182.75 64.36 
0 0.156 182.83 60.3 
0 0.235 182.88 63.46 
0 0.878 182.9 66.02 
0 0.53 183.22 62.8 
0 0.0127 183.22 50 
0 0.025 183.23 58.3 
No 
Occlusion 
35.05 3.72 182.41 86.6 
36.65 3.8 182.61 93.55 
31.35 1.07 182.71 66.6 
31.79 1.88 182.49 66.91 
35.73 2.27 182.76 74.72 
33.46 2.32 182.35 70.18 
32.43 1.79 182.54 75.2 
33.71 1.49 182.67 75.07 
 
 
Fig. 3.14: The normalized signal strength (left) and the resonant frequency (right) of the sensor 




Fig. 3.15: The quality factor of the sensor with respect to the flow rate through the stent for all 
measured cases. 
Although the signal strength shows a good correlation with the flow rate, the signal strength 
can also be changed by several other external factors like the position of the interrogation coils, 
sensor, etc. So it is not a reliable parameter to use for diagnosing occlusion. With further analysis, 
the ratio of the quality factor (Q) and the resonant frequency shift (Δfr) measured in each case is 
found to have a reasonable correlation with the flow rate measurements. This ratio is defined as 
the diagnostic parameter (Dp), and it increases when the flow rate is decreased due to the occlusion 
in the stent. The measurements are plotted in Fig. 3.16.   
 
Fig. 3.16: The ratio of the resonant frequency shift to the quality factor (Diagnostic parameter (Dp)) 
with respect to the flow rate through the stent. A flow rate <15 mL/min is assumed to be the 
therapeutic threshold with the stent in need of replacement.  
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The fully occluded cases with flow rate 0 mL/min gave values of Dp  as 5.9 Hz-1 to 17.4 Hz-1 while 
the zero/partial occlusion cases with flow rates >15 mL /min gave Dp  as  0 Hz-1 to 6.7 Hz-1.  
The clinical performance of the sensor with respect to the diagnostic parameter defined 
previously can be described in terms of diagnostic accuracy. The receiver operating characteristic 
(ROC) provides this diagnostic accuracy mathematically [Zwe93]. This is a generally used tool 
for evaluating the performance of diagnostic methods in the medical field [Par04]. The ROC of 
the sensor was identified for detecting stent occlusion using the diagnostic parameter, Dp, assuming 
that occlusions resulting in a flow rate below 15 mL/min should be considered as an occluded stent 
and must be replaced. The True Positive Rate (TPR), is calculated by: 
𝑇𝑇𝑇𝑇𝑇𝑇 =
∑𝑇𝑇𝑟𝑟𝑢𝑢𝑇𝑇 𝑇𝑇𝑃𝑃𝑠𝑠𝑃𝑃𝑡𝑡𝑃𝑃𝑃𝑃𝑇𝑇
∑𝐶𝐶𝑃𝑃𝐶𝐶𝑟𝑟𝑃𝑃𝑡𝑡𝑃𝑃𝑃𝑃𝐶𝐶 𝑇𝑇𝑃𝑃𝑠𝑠𝑃𝑃𝑡𝑡𝑃𝑃𝑃𝑃𝑇𝑇                                                 (3.6) 
where ∑𝐶𝐶𝑃𝑃𝐶𝐶𝑟𝑟𝑃𝑃𝑡𝑡𝑃𝑃𝑃𝑃𝐶𝐶 𝑇𝑇𝑃𝑃𝑠𝑠𝑃𝑃𝑡𝑡𝑃𝑃𝑃𝑃𝑇𝑇 = 11 since the total number of occluded cases is 11 (i.e. the flow 
rate  <15 mL /min). The false positive rate is calculated by: 
𝐹𝐹𝑟𝑟𝐹𝐹𝑠𝑠𝑇𝑇 𝑇𝑇𝑃𝑃𝑠𝑠𝑃𝑃𝑡𝑡𝑃𝑃𝑃𝑃𝑇𝑇 𝑇𝑇𝑟𝑟𝑡𝑡𝑇𝑇 =
∑𝐹𝐹𝑟𝑟𝐹𝐹𝑠𝑠𝑇𝑇 𝑇𝑇𝑃𝑃𝑠𝑠𝑃𝑃𝑡𝑡𝑃𝑃𝑃𝑃𝑇𝑇
∑𝐶𝐶𝑃𝑃𝐶𝐶𝑟𝑟𝑃𝑃𝑡𝑡𝑃𝑃𝑃𝑃𝐶𝐶 𝑁𝑁𝑇𝑇𝑁𝑁𝑟𝑟𝑡𝑡𝑃𝑃𝑃𝑃𝑇𝑇                                   (3.7) 
where ∑𝐶𝐶𝑃𝑃𝐶𝐶𝑟𝑟𝑃𝑃𝑡𝑡𝑃𝑃𝑃𝑃𝐶𝐶 𝑁𝑁𝑇𝑇𝑁𝑁𝑟𝑟𝑡𝑡𝑃𝑃𝑃𝑃𝑇𝑇 = 13 since the total number of non-occluded cases is 13 ( i.e. the 
flow rate >15 mL /min). The ROC curve is plotted in Fig. 3.17.  The maximum TPR of 1 is 
achieved with a false positive rate of only 0.08 for a detection threshold of 50% decrease in flow 
rate (i.e. 15 mL /min) through the stent due to occlusion. The area under the ROC plot indicates 




Fig. 3.17: ROC curve utilizing Dp for diagnosing occlusion in a biliary stent. 
 ROC curves for other parameters are also plotted in Fig. 3.18.  Accuracy (given by the area 
under the curve) when using resonant frequency shift as the indicative parameter for occlusion is 
91.55% while that when using quality factor is 95.14%. These are poorer than the previously 
defined diagnostic parameter which is the ratio of the resonant frequency shift to the quality factor. 
Note that the normalized signal strength parameter has a very robust ROC with an accuracy of 
98.56%, but in a clinical situation – where the interrogation distance and thus the signal strength 
may vary considerably from test to test – it is not likely to be as useful as the other amplitude-




Fig. 3.18: ROC curve for normalized signal strength (left top), resonant frequency shift (right top), 
and quality factor (bottom) for diagnosing occlusion in a biliary stent. 
Phase noise 
The physical fluctuations in a resonator subsequently perturb the phase of the oscillation 
and produce phase fluctuations. These phase fluctuations are converted into noise sidebands 
around the carrier. For an ideal resonator frequency response, there will be a single peak in the 
frequency spectrum at the exact resonance frequency of the carrier. In any real resonator, the phase 
variation generates two sidebands spaced from the carrier on both sides on a frequency spectrum. 





Fig. 3.19: Illustration of phase noise definition. 
The generated sideband is conventionally given by the ratio of noise power to carrier power 
for 1 Hz bandwidth with offset frequency from the carrier. This is defined as phase noise as a 
function of offset frequency as L(f) and given by [Yan06]: 
𝐿𝐿(𝑓𝑓) = 10𝐹𝐹𝑃𝑃𝑁𝑁 𝑃𝑃(𝑓𝑓𝑟𝑟+𝑓𝑓,1 𝐻𝐻𝐻𝐻)
𝑃𝑃(𝑓𝑓𝑟𝑟)
 𝑟𝑟𝐵𝐵𝑑𝑑/𝐻𝐻𝐻𝐻                                        (3.8) 
where P(fr) is the carrier power (power at the resonant frequency), and P(fr+f, 1Hz) is the single 
sideband power at frequency offset f from the carrier frequency fr with the measurement bandwidth 
of 1 Hz as shown in Fig 1. L(f) is thus in units of decibel referred to the carrier power per hertz 
(dBc/Hz).  
 An empirical formula for the phase noise of the resonator is given by Leeson’s equation 
[Lee66, Rhe95]: 










���  𝑟𝑟𝐵𝐵𝑑𝑑/𝐻𝐻𝐻𝐻                         (3.9) 
where F is the noise factor (assumed to be 1 for an ideal case), K is the Boltzmann constant (= 1.38 
× 10-23), T is the temperature (=300 K), fr  is the resonant frequency (=180.8 kHz, calculated 
experimentally), P(fr) is the power at resonant frequency (= 0.1 W, calculated experimentally), fc 
is the flicker corner frequency (assumed to be zero for ignoring flicker noise), Q is the quality 
factor (=507, calculated experimentally) and f is offset frequency at which the phase noise is 
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calculated. The phase noise is calculated for the resonator designed in this chapter and plotted in 
Fig. 3.20. 
 
Fig. 3.20: Phase noise of the resonator estimated using Leeson’s equation. 
The sensor was characterized using the interrogation module shown in Fig. 3.7. The coil 
was made of 10 turns each for the transmitting coil as well as the receiving coil. The coil diameter 
was 3.5 cm, and the width of the coil was 2.2 cm for a total 20 turns. Excitation current across 
transmit coils was 180 mA (peak to peak). Commercial Helmholtz coils were used for DC bias at 
1.2 G (with conversion factor 1 A ≈ 1 G).  
 The phase noise of the entire system is calculated as follows. The resonant response of the 
sensor in terms of amplitude (extracted from the sensor response experimentally), as well as power 




Fig. 3.21: Resonant response of the resonator in terms of amplitude (Left) and power (Right). 




  𝑊𝑊𝑟𝑟𝑡𝑡𝑡𝑡𝑠𝑠                                                            (3.10) 
where V(f) is the amplitude of the detected sensor sine wave signal at the excited frequency f. The 
resistance is assumed to be 1 Ω. Ideally, the response should have been a single impulse at the 
resonant frequency (180.8 kHz). The noise power spectral density is calculated as follows [Yan06]: 
𝑁𝑁𝑃𝑃𝑃𝑃𝑠𝑠𝑇𝑇 𝑠𝑠𝑠𝑠𝑇𝑇𝑑𝑑𝑡𝑡𝑟𝑟𝑟𝑟𝐹𝐹 𝑟𝑟𝑇𝑇𝐶𝐶𝑠𝑠𝑃𝑃𝑡𝑡𝑑𝑑 (𝑓𝑓) = �𝑇𝑇(𝑓𝑓𝑟𝑟 + 𝑓𝑓, 1 𝐻𝐻𝐻𝐻) = �
𝑉𝑉(𝑓𝑓𝑟𝑟+𝑓𝑓)2
2
      𝑉𝑉
√𝐻𝐻𝐻𝐻�
                 (3.11) 
where P(fr+f, 1Hz) is the side band power at an offset frequency of f in a 1 Hz bandwidth, and this 




Fig. 3.22: Noise power spectral density with respect to offset frequencies. 
The phase noise is calculated using the equation (3.8) and plotted below. 𝑇𝑇(𝑓𝑓𝑟𝑟) is the power 
at the resonant frequency. Power is calculated by squaring the amplitude value at each frequency. 
The resulting phase noise plot is shown in Fig. 3.23. 
 
Fig. 3.23: Phase noise with respect to offset frequencies. 
Total Noise Equivalent Magnetic Field 
 Random thermal agitation from the molecules in the environment affects the motion of any 
resonator. Using Equipartition theorem and Nyquist relation, the spectral density of the fluctuating 
noise force is given by [Gab93]: 
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𝐹𝐹 = �4𝐾𝐾𝑏𝑏𝑇𝑇𝑇𝑇   𝑁𝑁/√𝐻𝐻𝐻𝐻                                                       (3.12) 
where Kb is the Boltzmann constant, T is the temperature and b is the damping coefficient. The 






                                                (3.13) 
where k is the equivalent spring constant and 𝐺𝐺(𝑓𝑓) = 1 �[1− (𝑓𝑓 𝑓𝑓𝑟𝑟⁄ )2]2 + ((𝑓𝑓 𝑓𝑓𝑟𝑟⁄ )2 𝑄𝑄2⁄ )⁄ . For a 







                                            (3.14) 
where m is the effective mass and 𝜔𝜔𝑟𝑟 = �𝑘𝑘 𝑚𝑚⁄ .  
 Using the constitutive relation coupling the applied magnetic field and strain developed 
described in Chapter 1 equation (1.1)and assuming that for amorphous materials behave 




















































�                                                    (3.15) 
Considering an applied field and strain component only in the x-axis (i.e. strain 𝜀𝜀𝑥𝑥𝑥𝑥) for the 
longitudinal vibrations of a free-free beam magnetoelastic resonator gives: 
𝜀𝜀𝑥𝑥𝑥𝑥 = 𝑟𝑟𝑥𝑥𝑥𝑥𝐻𝐻𝑥𝑥                                                              (3.16) 
The equivalent force on the beam for generating this strain is given by: 
𝐹𝐹𝑠𝑠 = 𝐴𝐴𝐸𝐸𝜀𝜀𝑥𝑥𝑥𝑥 = 𝐴𝐴𝐸𝐸𝑟𝑟𝑥𝑥𝑥𝑥𝐻𝐻𝑥𝑥                                                      (3.17) 
where A is the cross-section area of the resonator and E is the young’s modulus. For the equivalent 








                                                     (3.18) 
For calculation of the total noise equivalent magnetic field (TNEM), the signal to noise ratio is 









−1/√𝐻𝐻𝐻𝐻                                       (3.20) 
 For calculating the TNEM for the mass loaded resonator, the effective mass was calculated 
from COMSOL FEA. The effective mass integral is given by [Com19]; 
𝑚𝑚 = ∫ 𝜌𝜌(𝑥𝑥)|𝑟𝑟(𝑥𝑥)|2𝑟𝑟𝑉𝑉                                                  (3.21) 
where ρ(x) is the density of the material and r(x) is the relative displacement. This equation can be 
integrated using COMSOL (in the derived values->volume integral) as; solid.rho*(solid.dsp/p)^2 
where p is the absolute displacement at the longitudinal endpoint. Using this technique, the 
effective mass is found to be 2.12 × 10-6 kg. The list of values required for using equation (3.10) 
is in Table 1. 
Table 3.2: List of values used for calculation of TNEM 
Parameter Value Source 
dxx 2.7 × 10-8 m A-1 [Gre09b] 
Q 507 Experimentally determined 
Kb 1.38 × 10-23 kg m2 K-1 s-2 Constant 
T 300 K Room temperature 
m 2.12 × 10-6 kg Estimated from COMSOL 
ωr 2π × 180,800 s-1 Estimated from COMSOL 
A 1.5 × 10-8 m2 Resonator dimension 
E 1011 kg m-1 s-2 Metglas datasheet 
Inserting the values from Table 1 in equation (10) gives 𝑇𝑇𝑁𝑁𝐸𝐸𝑀𝑀 = 0.275 p𝑇𝑇/√𝐻𝐻𝐻𝐻.  The total noise 
equivalent magnetic field (equation 3.20) can also be found by directly taking ratios of the noise 
force (equation 3.12) and the magnetoelastic force generated (equation 3.17). This noise is 
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relatively low and will not limit the performance because the noise from interface circuit 
dominates. The resolvable frequency shift from the whole system including interface circuits and 
related calculations are discussed in the following paragraph. 
Minimum Detectable Mass Load 
Two resonant peaks will be distinguishable only if they are apart by at least half power 
bandwidth. So, the minimum detectable frequency shift (𝛿𝛿𝑓𝑓) is given by [Bou16]: 
𝛿𝛿𝑓𝑓 = 𝑓𝑓𝑟𝑟
2𝑓𝑓
                                                             (3.22) 
where fr (180.8 kHz) is the resonant frequency and Q (=507) is the quality factor. The loaded mass 





− 1 = Δm
𝑀𝑀
                                                     (3.23) 
where M is the effective mass of the resonator. Using equation (1) and (2), Minimum detectable 







− 1� = Δm                                                   (3.24) 
The effective mass of the mass loaded resonator is 2.12 × 10-6 kg. This gives the minimum 
detectable mass load to be 4.24 × 10-9 kg. 
3.4 Summary and Conclusions  
A novel self-biased mass-loaded magnetoelastic sensor was designed, fabricated and 
tested. The sensor structure has two mass loads, one on each longitudinal end, which act as magnets 
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to bias the sensor while also preserving a low resonant frequency of the sensor despite its 
miniaturized footprint. The sensor was fabricated by bonding the sensor layer to the mass loads 
via an Au/In transient liquid phase bond. A hybrid coating approach using aluminum oxide 
followed by Parylene was used to ensure biocompatibility and corrosion protection after 
implantation. The sensor performance is evaluated by in vitro tests targeting the biomedical 
implant application of biliary stent monitoring. The sensor could detect synthetic occlusion in the 




4 Chapter 4: Hybrid In-stent Package for Biliary Stent Monitoring 
4.1 Introduction  
As discussed in Chapter 1 (1.3.2), one of the significant challenges in the implanted module 
for the biliary stent monitoring system is the mechanical protection of the sensor during and after 
implantation. As such, a package is required and the package must be both elastic enough to pass 
through the tight curvature during endoscopic deployment without experiencing permanent 
deformation and at the same time stiff enough to keep the sensor straight after implantation.  
 
Fig. 4.1: The biliary stent monitoring system consists of an interrogation module and the 
instrumented stent. The magnetoelastic sensor in a Nitinol-reinforced-polymer hybrid package 
mounted into a plastic stent.   
The hybrid package comprising a polymer structure reinforced by Nitinol wire is illustrated 
in Fig. 4.1. The polymer structure will hold the sensor in place while assembled in a stent and can 
be patterned with excellent resolution for very small sensors. Both the polymer (M3 crystal resin) 
and Nitinol are biocompatible and electromagnetically transparent.  The highly elastic Nitinol 
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reinforcements in this hybrid package provide the required flexibility to pass through the tight 
curvature of the endoscope, and also provide the elastic shape recovery to keep the sensor straight 
within the curved bile duct anatomy. The polymer structure provides a smooth surface that protects 
the resonator while the introducer is passed through the stent. The hybrid package also includes 
features that allow the sensor to detect sludge deposition. The sensing window enables the sludge 
to accumulate on the sensor directly, allowing the sensor frequency response to be affected as 
intended. The polyethylene (PE) tether holes are for integrating and assembling the package onto 
the inner wall of the stent. The package also has a dedicated cavity in which to insert the sensor 
and keep the sensor secured in place, while also allowing the sensor to vibrate as necessary. This 
chapter describes the design and fabrication of the hybrid package, as well as its assembly into 
stent followed by benchtop and in vitro experimental methods, results, and conclusions. 
4.2 Design, Fabrication and Assembly  
 Integrating the hybrid package into the stent increases the local bending stiffness of the 
stent. The change in stiffness is evaluated using the finite element analysis (FEA) tool COMSOL 
MultiphysicsTM. The model used consists of a segment of a 10 Fr (3.3 mm) diameter stent with the 
hybrid package attached to the inner side wall. A cross-sectional view of this is illustrated in Fig. 
4.2(a). The Nitinol wires are inserted into the designated channels in the polymer portion, and for 
the purposes of simplifying the model assumed to be “bonded” to the adjacent polymer structure. 
The material properties used for the stent are those of polyethylene (E = 0.7 GPa ρ = 0.95 g/cm3, 
ν = 0.42) and for the polymer part of the package are those of M3 crystal resin (E = 1.46 GPa,         
ρ = 1.02 g/cm3, ν = 0.42) and for the wires those of Nitinol (E = 80 GPa, ρ = 6.45 g/cm3, ν = 0.33). 
The classical “three-point bending test” is replicated when defining the load and boundary 
conditions.  Points a and b have zero displacement along the y-axis to prevent rolling while point 
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c is fixed in all directions. The point d has zero displacement in y and z directions but can move 
along the x-axis. The external force is applied on a 1 mm length at the center of the stent segment. 
The force applied in the negative z-direction increases from 0 to 10 N. Nonlinear large 
deformations were allowed when solving the model. Fig. 4.2(b) shows the deformed hybrid 
package when the applied force is 10 N. (The deformed stent is not shown in this view). The 
maximum deformation of the package is 0.56 mm. The deformation against the applied force is 
plotted in Fig. 4.3. As expected, the bending stiffness of the stent is increased with the attachment 
of the hybrid package. The initial bending stiffness without a hybrid package is 15.5 N/mm and is 
increased by 12.79% to 17.78 N/mm with the attachment of the hybrid package.   
 
Fig. 4.2: (a) Cross-sectional view of a stent segment with the hybrid package used in the 
simulation. The stent segment length is 12 mm.  The external force is applied on the green surface 
of the stent.(b) FEA simulation result showing the deformation of the hybrid package under an 





Fig. 4.3: Simulated displacement of the stent segment with and without the hybrid package due to 
the externally applied force.The bending stiffness increased from 15.5 N/mm to 17.78 N/mm 
(12.79%) after integrating the hybrid package. 
 
The polymer structure in the hybrid package was fabricated using 3D printing technology. 
A high-resolution multi-jet 3D printer (ProJet 3500 HD Max) with a resolution of 16 µm was used 
to print this structure using M3 crystal resin. This resin is USP class VI biocompatible rated and 
ideal for printing highly detailed features within tight tolerances. The Nitinol wires (superelastic 
condition) with a diameter of 125 µm were acquired from Small Parts and cut to ~10 mm using a 
shear tool. A photograph of a fabricated polymer structure along with Nitinol wires is shown in 
Fig. 4.4. Photograph of the sensor packaged in the polymer package reinforced with the Nitinol 
wires is shown in Fig. 4.5. 
 





Fig. 4.5: Sensor in the hybrid nitinol reinforced hybrid package. 
 
 The sensor is packaged by inserting into the designated slot in the polymer structure of the 
hybrid package; the package is reinforced with Nitinol wires inserted into the channels on the 
sides. The packaged sensor is then integrated into an 8 cm, 10 Fr plastic stent (Cook Cotton-Leung 
Biliary Stent, CLSO-10-8). A small incision was made on one side of the stent, and the flap was 
peeled back partially. Then, the packaged sensor was inserted into the stent. Polyethylene (PE) 
tethers were passed through the holes on the package through the stents. PE threads were tightened 
and then melted onto the outer stent wall to conform to the smooth surface of the stent. Partially 
peeled stent flaps were placed back into their original position and then re-melted into the nearby 
stent material. The assembly process is illustrated in Fig. 4.6. The stent instrumented with the 




Fig. 4.6: Steps involved in assembling a packaged sensor to a commercial stent. Step I: Upper part 
of the stent is peeled off partially,and the hybrid packaged sensor was placed inside with PE tethers 
through the holes of the package as well as the holes made on the stent. Step II is sealing back the 
peeled part of the stent and melting the PE tethers to the outer wall of the stent. The cross-sectional 
view of the stent/package after step I (Inset) 
 
Fig. 4.7: Packaged sensor assembled in a commercial 10 Fr stent. 
4.3 Experimental Results 
Bending experiments  
Bending tests were performed on instrumented stents, in which various radii of curvature 
(ROCs) were imparted to the stent, and the sensor was simultaneously interrogated to evaluate 
signal attenuation.  The instrumented stents were also passed through an endoscope as in a typical 
delivery process, passing through the tightest curvature achievable (~2 cm) with the endoscope.  
Afterward, each sensor was interrogated, and any mechanical damage was visually evaluated.  The 
goal of these tests was to ensure that the sensor signal is not significantly affected while the stent 
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is curved inside the bile duct and also to ensure that the sensor/package is not damaged while 
passing through the endoscope.   
The first sets of bending tests were focused on evaluating the ability of the package to keep 
the sensor straight if implanted in an inherently curved bile. The stent was placed inside a polymer 
tube, which was fixed on one end. The other end of the tube was deflected to impose various radii 
of curvature onto the stent, reducing from 10 cm to 4 cm (Fig. 4.8).  
 
Fig. 4.8: Bending tests performed on the instrumented stent involves a fixture used to bend the 
stent to a required curvature ‘r’ (Top). The instrumented stent was bent in all three directions 
(Bottom). 
The sensor was interrogated while the stent was bent.  Typical acquired frequency responses for 
convex bending are shown in Fig. 4.9, 4.10 and 4.11. For the convex bent cases, the maximum 
shift in the resonant frequency was only by 0.02% (RC of 6 cm) and the maximum decrease in the 
quality factor was by 12.5% (RC of 8 cm). For the concave bent cases, the maximum shift in the 
resonant frequency was only by 1.01% (RC of 4 cm). For the lateral bent cases, the maximum shift 




Fig. 4.9: Typical frequency responses when the instrumented stent was bent in various radii of 
convex curvature.  
 
Fig. 4.10: Frequency response when the instrumented stent is bent in the concave direction.  
 
Fig. 4.11: Frequency response when the instrumented stent is bent in the lateral direction.  
The signal strength decreased for some bent cases, but there were no cases exhibiting total signal 
loss. These results indicate that there will not be any noticeable effect on the signal response when 
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the instrumented stent is bent by an inherently curved anatomical bile duct. The package is 
practically stiff enough to keep the sensor straight under the expected externally applied stress. 
The next set of bending tests were performed in order to evaluate the ability of the package 
to pass through the tight curvature at the end of the endoscope when the elevator is raised, resulting 
in a Rc of ~2 cm. For this, the stent was passed through the endoscope in a full deployment process 
(Endoscope I). The endoscopic procedure was repeated twice more (Endoscope II, Endoscope III). 
The results of these tests are plotted in Fig. 4.12. The maximum shift in resonant frequency was 
only by 0.14% (Endoscope III), and the maximum decrease in the quality factor was by 26% 
(Endoscope III). The signal strength was reduced to as low as 40% of the original value. The 
package was inspected after all these experiments. There was no damage to the sensor as well as 
the package. These experiments show that the hybrid package is flexible enough to go through this 
intense radius of curvature and still elastically recover its original shape without getting damaged. 
A reasonable signal was observed for all the test cases. This indicates that the integrity of the 
sensor, as well as the package, is maintained. 
 
Fig. 4.12: Frequency responses after the instrumented stent is passed through an endoscope 
multiple times.   
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In vitro experiments 
In vitro experiments were conducted to evaluate the effect of the presence of the package 
(with sensor) in the stent with respect to biomass deposition and occlusion development. An 
accelerated in vitro model created sludge deposition inside the stent using fiber-rich bile inoculated 
with Escherichia Coli [Sur18]. Nutrient media for culturing the bacteria was prepared by adding 
dextrose (100 mg), ammonium sulfate (100 mg), potassium phosphate dibasic (700 mg), potassium 
phosphate monobasic (200 mg), magnesium sulfate heptahydrate (50 mg), and sodium citrate      
(10 mg), to 100 mL distilled water. The components were mixed well, and 10% bile powder 
(Oxgall, US Biological) was added to the media. The media was then autoclaved to ensure sterility. 
Escherichia Coli (ATCC 25922) was cultured in this solution and then allowed 10 passages in 
order to make the bacteria bile resistant. The bile-resistant bacteria were stocked with 20% glycerol 
at -20oC for future use.  
 
Fig. 4.13: The in vitro experimental set-up.  
The schematic of the flow set-up is shown in Fig. 4.13. A dual-channel peristaltic pump, 
in combination with a network of tubes, was used to mimic the bile flow. Each experimental set 
consisted of two stents: one instrumented and the other non-instrumented.  The stents were 
connected to the flow system in separate channels. The bile reservoir contained 90 mL of 10% bile 
with bacteria cultured to an optical density of 0.4 - 0.8. Fiber (0.5 g, CreaFibe SC90) was added to 
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the reservoir to mimic dietary fiber in the bile.  The reservoir was kept at 36oC - 38oC via a heated 
water bath, which helped to keep the bile solution at a uniform temperature. The temperature was 
measured intermittently using a probe, and the reservoir was kept closed at all other times to reduce 
evaporation.  A magnetic mixer inside the inoculated bile reservoir was used to mix at 600 rpm; 
this kept the fiber suspended in the bile rather than settling to the bottom of the reservoir. Then, 
the bile was pumped through the channels and the stents at a flow rate of ≈0.5 mL/min. The section 
of the channels where the stents were located was immersed in a heated sand bath, which was kept 
at a constant temperature of 37 oC. Once the stents became occluded, they were removed from the 
test-setup and interrogated. Full occlusion is defined when the flow through the channel was 
observed to have stopped, and occlusion was confirmed by applying 0.5-inch height water pressure 
to the stent (~124 Pa) and observing no water flow. Experiments on five sets of stents were 
conducted.  Photos of a representative set of occluded stents are shown in Fig. 4.14. The stents 
were primarily occluded in the inlet of the stents. The times taken for occlusion of the stents are 
listed in Table 4.1.  
 




Table 4.1: In vitro results, stent occlusion time for instrumented, non-instrumented 8 cm stents. 
sensor performance, RF – resonant frequency, QF – quality factor. 
Exp 
# 
Occlusion Time (Hrs) 
Instr. (ti) Non-instr. (tn) 
1 6.5 8 
2 7 5 
3 6.5 5.5 
4 6 6.5 
5 7 5 
6 8 6.5 
7 6.5 5.5 
 
There is no clear or obvious acceleration of occlusion due to the presence of the 
sensor/package from these experiments. A non-inferiority test was done on these results and 
discussed in the next section. The sensor resonant characteristics before and after occlusion in the 
instrumented stents are listed in Table 4.2.  
Table 4.2: In vitro results, resonant frequency (RF), quality factor (QF). 
Exp. 
# 




in QF RF (kHz) QF RF (kHz) QF 
1 259.7 130 261.2 98 1.5 32 
2 256.8 135 258.1 109 0.7 26 
3 256.3 114 257.8 102 1.5 12 
4 260.4 161 259.8 125 0.6 36 
5 259.7 120 261 94 1.3 26 
6 256.8 118 257.3 99 0.5 19 
7 257.2 115 259.2 90 2 25 
 
There is a noticeable resonant response change after the occlusion. There is a shift in the 
resonant frequency by at least 0.6 kHz up to 2 kHz after occlusion. Also, the quality factor 
86 
 
decreases by at least 12 and as much as 36 after occlusion. This indicates that the sensor can be 
utilized to discern full occlusion in the instrumented stents.  
Non-inferiority Test  
Randomized controlled trials (RCT) are carried out to compare a new experimental 
procedure/treatment/medicine to an existing procedure/treatment/medicine [Les08]. The RCT is 
called a superiority test when the trial is to prove that the new treatment is superior to the existing 
one.  If the objective is to show that they are equivalent, it is called an equivalency test. Finally, a 
non-inferiority (NI) test is used to evaluate whether the new treatment is not unacceptably less 
effective than the existing treatment [Hah12]. These tests use the outcome of the trials to determine 
the superiority/equivalence/non-inferiority. If all the outcomes from the new treatment are better 
than the existing one, the new treatment is superior. If all the outcomes of the new method are 
close to the existing method within a predefined margin of δ, they are equivalent. Finally, if the 
new treatment outcomes are not worse than the existing method with at least a margin of δ, the 
new method is found non-inferior to the existing method. These concepts are illustrated in Fig. 
4.15.  
 




A student t-test using the test statistic t-score can be used to further quantify the outcome of these 
tests. Calculation of the t-score and corresponding p-value (i.e. marginal significance) helps to 
determine the significance of the results [Mas11].  
A non-inferiority test RCT is chosen here. This test determines whether the new 
intervention is clinically non-inferior, but still beneficial for patients in terms of other advantages 
like less-intensive treatment, lower cost or fewer side effects [Reh16, Las03]. Here, the 
instrumented stent offers the advantage of occlusion detection but could be inferior in terms of the 
stent occlusion time, due to the presence of the sensor and package. The NI test is utilized to 
demonstrate that the instrumented stent is not inferior to the non-instrumented stents in terms of 
occlusion time. The null hypothesis is that the instrumented stent occludes faster than non-
instrumented stents by at least δ hrs. Mathematically, the mean of occlusion time for instrumented 
stents (µi) is worse than occlusion time for non-instrumented stents (µs) by at least δ hrs: 
𝐻𝐻0: µ𝑖𝑖 − µ𝑠𝑠 ≤ −𝛿𝛿                                                              (4.1) 
The alternative hypothesis is that the instrument stent does not occlude faster than non-
instrumented stents or occludes faster but not worse than a difference in occlusion time of δ hrs. 
Mathematically: 
𝐻𝐻𝑎𝑎 : µ𝑖𝑖 − µ𝑠𝑠 > −𝛿𝛿                                                               (4.2) 
 The test statistic, t-score for the test for samples with unequal variances and sample sizes 
is given by [Mas11]: 






                                                               (4.3) 
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                                                            (4.4) 
where 𝑆𝑆𝑖𝑖 and 𝑆𝑆𝑠𝑠 are the observed standard deviation of the set of instrumented stents and non-
instrumented stents, respectively. For 𝐶𝐶𝑖𝑖 = 𝐶𝐶𝑠𝑠 = 𝐶𝐶, (4.3) reduces to: 




                                                                     (4.5) 
For the observations in Table 4.1, µ𝑖𝑖 = 6.79, µ𝑠𝑠 = 6, 𝑆𝑆𝑖𝑖 = 0.40, 𝑆𝑆𝑠𝑠 = 1.17, 𝐶𝐶 = 7. The NI 
margin is chosen so that the 𝛿𝛿 = 0.1µ𝑠𝑠 = 0.6. This margin is a 90% fraction of µ𝑠𝑠 which is 
generally used in the field of antibiotics [Alt17]. For this NI margin, the t-score calculated from 
(4.4) is 2.92. The corresponding p-value at a significance level of 0.05 (95%) is 0.0133 (one-tailed 
test, calculated using a p-value calculator [Soc19]). The result is significant since p <0.05. The 
result is graphically shown in Fig. 4.16. 
 
Fig. 4.16: Graphical representation of non-inferiority of occlusion time of instrumented 8 cm stents 
to the occlusion time of non-instrumented stents. 
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Long stents were not available for more experiments, hence shorter 3 cm stent pieces were 
used to gather more data on occlusion dynamics. The times taken for occlusion of the stent pieces 
are listed in Table 4.3. The sensor performance is listed in Table 4.4. 
Table 4.3: In vitro results, stent occlusion time for instrumented, non-instrumented 3 cm stents. 
sensor performance, RF – resonant frequency, QF – quality factor (Shorter Stents). 
Exp. 
# 
Occlusion Time (Hrs) 
Instr. Non-instr. 
1 6 7 
2 6.5 6 
3 6 5.5 
4 7 7 
5 5 5.5 
6 5.5 6 
 
Table 4.4: In vitro results, resonant frequency (RF), quality factor (QF) (Shorter Stents). 
Exp. 
# 




in QF RF (kHz) QF RF (kHz) QF 
1 259.9 138 260.2 115 0.3 23 
2 252.0 105 255.0 85 3 20 
3 260.8 123 261.4 84 0.6 39 
4 259.0 115 259.9 93 0.9 22 
5 257.6 116 258.4 98 0.8 18 
6 255.5 127 257.5 103 2 24 
Experiments with shorter stents also showed that the sensor could detect occlusion in terms of a 
shift in resonant frequency and a decrease in quality factor. Further, there is no obvious 
acceleration in occlusion time for the instrumented stent pieces compared non-instrumented stent 
pieces. This experimental data leads to the conclusion that the presence of packaged sensor does 
not have any meaningful negative impact on the occlusion dynamics. 
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4.4 Summary and Conclusions 
A hybrid metal-polymer package is designed to protect magnetoelastic sensors used in a 
wireless biliary stent monitoring system. The hybrid package is made of a polymer structure 
reinforced with highly elastic Nitinol wires. Bending tests were conducted on the package-
integrated stents and found that the package is flexible enough to pass through the endoscopic 
procedure and protect the sensor without any damage. In addition, experiments show the package 
aids in maintaining local stent straightness while the stent is deployed inside the inherently curved 
bile duct to minimize the signal attenuation due to sensor bending. Finally, in vitro, experiments 
were conducted to evaluate the effect of the presence of the package in terms of occlusion time. 
An accelerated stent occlusion model utilized cultured bacteria to create the sludge development 
and occlusion inside both instrumented and non-instrumented (control) stents. Using a statistical 
non-inferiority test, it was found that the instrumented stents are not inferior to the non-





5 Chapter 5: Interrogation Module for Biliary Stent Monitoring 
5.1 Introduction 
 A magnetoelastic system for biliary stent monitoring consists of a magnetoelastic sensor 
and an external interrogation module for remotely interacting with the implanted sensor.  
Typically, the sensor is excited with a magnetic field, but the sensor response can be detected via 
magnetic, acoustic, or optical means [Gri11].  Optical means that require phototransistor/laser are 
not feasible in an implanted situation as an implanted sensor is obscured from illumination by 
tissue.  Acoustic approaches have yet to demonstrate a substantial wireless range [Nam17].  As 
such, the system developed in this work excites the sensor and detects the sensor response in the 
magnetic domain.  The system consists of a set of inductive coils to generate the magnetic field 
for exciting the sensor and for detecting the magnetic field generated by the sensor, along with 
various hardware components.  Also, to be considered are the application specific challenges 
facing biliary stent monitoring, including (i) signal feedthrough, (ii) wireless range, and (iii) 
clinical utility.  These are discussed in detail in a previous chapter (Section 1.2.3). Along with the 
packaged sensor, the complete magnetoelastic system is illustrated in Fig. 5.1. This chapter 
discusses the design and implementation of the interrogation module and demonstration of the 
module in benchtop experiments, in vitro, in situ and in vivo.  The approach used in developing 




Fig. 5.1: The biliary stent monitoring system consists of  a magnetoelastic sensor integrated with 
the biliary stent for detecting occlusion (left) and the interrogation module (right). 
 The interrogation module consists of transmit coils for exciting the sensor magnetically 
and a receive coil for sensing the magnetic field produced by the vibrating sensor.  The waveform 
generator (National Instruments, NI-5412) along with the buffer amplifier (Texas Instruments, TI 
BUF634P) delivers the required sinusoidal voltage across and current through the transmit coil.  
As indicated in a previous chapter (Section 1.2.3), a time domain decoupling approach is used here 
to minimize the signal feedthrough.  Hence, the interrogation cycle consists of a transmit part 
which is a burst sinusoid and a receive part where no voltage is generated and instead the sensor 
ringdown is detected. The magnetic field generated by the transmit coil as a result of the sinusoidal 
current excites the sensor, and the sensor responds with its own magnetic field while it vibrates.  
This sensor-generated magnetic field will create a current through the receive coil, and this is 
amplified and converted to a voltage using a low noise amplifier (LNA) (Stanford Research 
Systems, SR-570) and acquired to a data acquisition device (NI-6115) for further processing.  The 
protection circuit blocks and shunts large input currents away from the low noise amplifier; these 
currents would otherwise arrive at the low noise amplifier input during the transmit portions of the 
interrogation cycle due to mutual induction between the transmit and receive coils. 
93 
 
 The following sections describe the hardware implementation of the interrogation module 
and the details of the digital signal processing steps implemented.  Further, in vitro experimental 
results as well as in situ experimental results are detailed, followed by conclusions.  
5.2 Hardware Implementation 
 As indicated previously, the major challenges focused on in developing the interrogation 
module are (i) signal feedthrough (ii) wireless range (iii) clinical utility.  The hardware used in the 
interrogation module is carefully selected and designed to overcome these challenges. These 
hardware consists of transmit/receive coils; the waveform generator and buffer amplifier on the 
transmit side; and the LNA, protection circuit and data acquisition device on the receiving side. 
The specific purpose of these hardware components in achieving the goal of signal feedthrough 
elimination, wireless range improvement and clinical utility is detailed in the following sections. 
 Transmit/Receive Coils: The receive coil and the transmit coils were fabricated considering 
the clinical utility and matching their impedance with specifications of the next instrument in the 
system for the improved efficiency.  For the transmit coils, the generated magnetic field is 
maximized by optimizing the number of turns of the coil and the current through them.  The 
impedance of the coils must be matched to the buffer amplifier for this optimization.  The transmit 
coil can be modeled as a multi-turn coil with radius rc and width ac as shown in Fig. 5.2.  
 
Fig. 5.2: Transmit coil modeled as a simple multi-turn cylindrical coil with radius rc and width ac. 
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Using the Biot-Savart law, the magnetic field at the center (position Ac in Fig. 5.2) is given by: 
𝐵𝐵 = µ0𝑁𝑁𝑁𝑁
2𝑟𝑟𝑐𝑐
                                                              (5.1) 
where, µ0 is the permeability in vacuum, I is the RMS current, r is the radius of the coil, and N is 




𝑚𝑚𝐻𝐻                                                           (5.2) 
where rc (~0.1 m) is the radius, a is the width of the coil and N is the number of turns in 
the coil.  This equation is valid for 2rc > ac > 0.2rc.  For the wire used, the width per turn is 
measured to be 1.25 × 10-3 m, resulting in total width, ac, of N × 1.25 × 10-3 m.  The resistance of 
the coils is relatively small compared to the reactance presented by the inductance and thus is 




𝑚𝑚𝑚𝑚                                                     (5.3) 
where ω (= 2πf,  f  = 155 kHz – the expected resonant frequency of the resonator) is the 
radial frequency of the signal.  Equating the coil impedance to 50 Ω and using equation (5.3), it is 
found that two parallel coils with 14 turns in each will be the optimum for maximizing the 
generated magnetic field at the expected sensor frequency.  A current of 0.125 A through each of 
these coils will result in a magnetic field of ≈0.2 G. 
The sensing side of the interrogation module consists of the receive coil connected in series 
with the protection circuit, LNA, and data acquisition device.  The number of turns of the receive 
coil is optimized for maximum current generation for a given magnetic flux density, as the LNA 
is a transimpedance amplifier.  In this case, the receive coil is connected in series with a switch, 
protection circuit, and the LNA.  The equivalent resistance of these circuit elements is estimated 
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to be 365 Ω.  The receive coil acts as a voltage source while the magnetic field generated by the 
magnetoelastic sensor couples with it.  This can be modeled as the circuit shown in Fig. 5.3. 
 
Fig. 5.3: Receiving circuit modeled with a voltage source for illustrating impedance matching. 
 The voltage V generated across the coil by varying magnetic field is given by Faraday’s 
law of electromagnetism: 
𝑉𝑉 = −𝑁𝑁 𝑑𝑑Φ
𝑑𝑑𝑡𝑡
= −𝑁𝑁𝜔𝜔Φ                                                            (5.4) 
where 𝛷𝛷 is the magnetic field, ω is the frequency and t is the time.  The current generated 
through the circuit is given by: 
   𝐼𝐼𝑐𝑐 =
𝑉𝑉
𝑍𝑍𝐶𝐶𝐶𝐶𝑖𝑖𝐶𝐶+𝑍𝑍𝐿𝐿𝐶𝐶𝐿𝐿𝐿𝐿
                                                            (5.5) 
where Zcoil is the impedance of the coil and ZLoad is the impedance of the load (365 Ω).  Since this 
is a multi-turn coil, we can use Eq. (5.3) to estimate the coil impedance.  Simplifying Eq. (5.3) 
shows that the Zcoil is approximately proportional to the square of N. This gives: 
 𝑍𝑍𝐶𝐶𝐶𝐶𝑖𝑖𝐶𝐶 = 𝑚𝑚𝑁𝑁2𝜔𝜔                                                              (5.6) 
where m is a constant of proportionality.  Equations (5.4), (5.5) and (5.6) gives the current through 




                                                          (5.7) 
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From this, it is clear that for a given frequency, the highest current magnitude is generated when 
N is chosen such that ZCoil is equal to ZLoad. Using equation (5.7), it is found that a single coil with 
28 turns is expected to provide optimum sensitivity. 
Considering clinical utility, rigid cylindrical coils are not ideal for use on patients of various 
sizes, so the coils have been reimagined in the style of a belt.  The belt can be first disconnected at 
the ends, then wrapped around the midsection of the patient, then reconnected (Fig. 5.4).  The 
transmit and receive coils have been fabricated from standard ribbon cables, with the connectors 
offset so as to form a continuous coil as shown in Fig. 5.4.  All the coils are enclosed in nylon 
fabric as an added layer of structural integrity and electrical isolation.  The position of the coils is 
maintained within the nylon fabric by stitching between each coil.  Hook and loop connectors 
(Velcro) are used for form-fitting placement of the coil module around the midsection of the patient 
while allowing the dimensions of the resulting inductive loop to be adjusted within a useful range.  
This belt can be placed around a patient and formed into a coil using the standard snap-together 
ribbon cable connectors.  These coils will be positioned on the body of the patient so that the 





Fig. 5.4: Coil structure and clinical utility.  The offset connection for the fabrication of a continuous 
coil from ribbon cable is also illustrated in the lower left. 
 Waveform generator and buffer amplifier: The waveform generator and buffer amplifier 
circuit are used to generate the burst sinusoid voltage across the transmit coils.  The waveform 
generator is programmed in LabVIEW to generate the burst sinusoidal signal with the specified 
transmit and receive time.  Transmit time corresponds to the duration of time in which the sensor 
is excited and receive time corresponds to the time where there is no transmit signal, but the sensor 
signals are acquired.  In short, the waveform generator along with the buffer amplifier enables the 
implementation of time domain decoupling for signal feedthrough elimination. 
 The buffer amplifier acts as a buffer between the waveform generator and the coils. The 
buffer amplifier circuit also includes a metal oxide varistor (MOV) (Littlefuse V18ZA2P) as 




Fig. 5.5: Buffer circuit with the MOV for flyback voltage protection for the sine wave generator. 
The MOV is used to protect the buffer amplifier from flyback voltage across the transmit coils as 
they are switched off.  A MOV has a nonlinear current-voltage characteristic that is similar to that 
of a diode.  The I-V characteristic of the MOV was measured experimentally and is shown in Fig. 
5.6.  This protects the amplifier from any flyback voltage of more than +/-12 V. 
 
Fig. 5.6: I-V characteristics of the MOV. 
Low noise amplifier, protection circuit and data acquisition device: The hardware 
components at the sensor signal reception side are the LNA, protection circuit and data acquisition 
device.  The LNA amplifies the received signal while introducing minimal noise, which helps in 
improving the SNR which will subsequently improve the wireless range.  The protection circuit is 
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for protecting the LNA from overdrive. Finally, the received signal is collected to a PC using a 
data acquisition device. 
The selection of various settings on the LNA – including the passband of onboard filters, 
sensitivity, and high-bandwidth or low noise mode – determine its response.  The passband for the 
LNA is set after estimating the sensor resonance frequency.  The sensor resonance frequency fr, 






                                                               (5.8) 
where l is the length of the sensor, Y is the elastic modulus of the sensor, and ρ is the mass density 
of the sensor.  This is experimentally found to be ≈160 kHz.  Thus, the LNA is set to have a 
bandpass filter with passband 10 kHz - 300 kHz for rejecting the higher and lower frequency noise.  
The sensitivity is optimized experimentally at 20 µA/V for the best signal to noise ratio while 
avoiding overload of the LNA input or output.  The high-bandwidth mode is utilized to ensure the 
LNA can capture signals near 100 kHz.  The noise specification for the LNA with these sensitivity 
and mode settings is 60 pA/√Hz.   
 The protection circuit, placed between the output of the receive coils and the input of the 
LNA, is used to avoid overloading of the LNA. The protection circuit (Fig. 5.7) consists of an 
analog CMOS switch and antiparallel Schottky diodes (Vishay BAT46-TR).  
 
Fig. 5.7: Protection circuit for LNA with Schottky diodes. 
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The switch in the protection circuit is used to avoid overloading of the LNA input due to the mutual 
induction between the transmit coils and the receive coil during the transmit period.  The switch 
logic is programmed in LabVIEW so that it is “off” during the transmit period and “on” during the 
receiving period.  The Schottky diodes turn on limiting the maximum current to the LNA even if 
the switch fails in a short condition.  A blank signal at the LNA was also used to avoid output 
overloading during the transmit period.  This blank signal keeps the gain of the amplifier at 0 dB 
during the transmit phase and back to the 20 µA/V gain during the receiving phase. 
 A typical timing diagram for the transmit signal, switch logic and the blank signal is shown 
in Fig. 5.8. The transmit time and receive time utilized is chosen from 4 ms to 12 ms depending 
on the time constant of the received ringdown signal.  
 




The blank signal is delayed by 200 µs in order to avoid overload at the output of the LNA due to 
the ringdown of the transmit signal itself and the switching transients.  The switch logic is delayed 
by 68 µs to avoid overload at the input of the LNA due to the ringdown of transmit signal that 
couples through the receive coil.  These values are determined experimentally.  The ON time of 
the switch logic varies from 8 ms to 10 ms and the program delay varies from 12 ms to 16 ms 
depending on the execution time of the LabVIEW code. 
 Finally, the amplified signal from the LNA is collected to a PC using a data acquisition 
device for further digital signal processing and display of results.  This device collects the voltage 
data from the LNA at a 1 MHz sampling rate during the receive period.  The collection of all the 
voltage data after the LNA helps to apply several signal processing techniques to improve the SNR 
and subsequently the wireless range. The signal processing steps are detailed in the next section. 
5.3 Digital Signal Processing 
 The signal after the LNA is still noisy and extraction of any useful information requires 
further processing.  A series of digital signal processing techniques were used to minimize the 
noise and recover the sensor signal.  These techniques help to improve the SNR and an improved 
SNR allows improvement of the wireless range.  The flow diagram of these techniques is illustrated 
in Fig. 5.9.  
 
Fig. 5.9: Schematic of digital signal processing techniques implemented. SSSA is the Summed 
Squared Signal Amplitude and GDC is Group Delay Compensation. 
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 The data acquired into the PC is divided into two segments of time.  The first half, during 
which the ringdown signal will be the strongest, represents the sensor “signal”; while the second 
half is considered as the background “noise”.  This helps to evaluate the SNR by taking the real-
time, frequency specific noise signature into account.  For instance, Fig. 5.10 shows a typical signal 
response from the sensor during the measurement time.  The first 12 ms represents the sensor 
signal while the remaining 12 ms represents the real-time noise in the system.  Since the 
measurement is taken for 24 ms of time at a sampling rate of 1 million samples per second, each 
half of the data trace consists of 12,000 data points. The steps involved in the digital signal 
processing are listed in Table 5.1. 
Table 5.1: Steps involved in digital signal processing. 
Step 1 Averaging 
Step 2 Switch peak removal 
Step 3 Cascading moving bandpass filter 
Step 4 Quadrature mixing and magnitude calculation 
Step 5 Lowpass filter 
Step 6 Selective Kalman filtering 
 
Fig. 5.10: Left – “Signal” data. Right – “Noise” data of the raw signal before DSP. 
Step 1 - Averaging 
 The strength of white noise present in the signal can be reduced by taking an average of 
several data traces of the signal.  In this step, 10 data traces are averaged over time in order to 
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reduce random white noise.  This is illustrated in Fig. 5.11. More traces can be averaged to further 
reduce noise at the cost of total interrogation time.  
 
Fig. 5.11: Left – “Signal” data after step 1, averaging.  Right – “Noise” data after step 1, averaging. 
Step 2 – Switch peak removal 
 The distinct peak of amplitude 0.4 V (negative going) at the beginning of the signal is due 
to the switching that happens in the LNA when the blanking signal is toggled.  This specific pulse 
lasts only for approximately 29 µs, and hence, 29 initial samples are removed from the data trace. 
This is illustrated in Fig. 5.12.    
 
Fig. 5.12: Left – “Signal” data after step 2, removal of LNA gain toggling.  Right – “Noise” data 
after step 2, removal of the peak from LNA gain toggling. 
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Step 3 – Cascaded moving bandpass filter 
 This step filters out high and low noise frequency – compared to the center frequency at 
each point in the sweep – using a narrow digital bandpass filter.  The bandpass filter designed is a 
finite impulse response (FIR) filter. An FIR filter is a filter which has an impulse response of finite 
duration while an Infinite Impulse Response (IIR) filter continues to respond indefinitely. Because 
of this inherent nature, an FIR filter has guaranteed stability and an exactly linear phase. [Lit00, 
Eli13]. Hence, an FIR filter is chosen over an IIR filter. This property of having linear phase results 
in constant group delay for all frequency components of the signal while filtering.  This is an 
important advantage in group delay compensation and for avoiding distortion of the signal.  A 
linear phase FIR filter is designed using the Remez exchange algorithm to minimize the maximum 
error between the target frequency response and the designed filter frequency response.  This error 
specification yields filters with equi-ripple or Chebyshev error behavior [Cet97].   
A cascaded filter approach is used here by cascading two bandpass filters.  Two bandpass 
filters with slightly offset bandpass frequencies are cascaded in order to achieve a narrow filter 
with the central frequency, Cf.  The specifications of the bandpass/ stopband frequencies of these 
filters are listed in Table 5.2.  The resulting number of taps, or filter coefficients, that are required 
to meet the bandpass filter specifications below is approximately 500. 
Table 5.2. Frequency details of the filters implemented 
 Bandpass Filter I Bandpass Filter II Cascaded Filter 
Central frequency Cf1=Cf – 600 Hz Cf2=Cf + 600 Hz Cf 
Passband frequency 1 Cf1 – 1000 Hz Cf2 – 1000 Hz Cf – 300 Hz 
Passband frequency 2 Cf1 + 1000 Hz Cf2 + 1000 Hz Cf + 300 Hz 
Stopband frequency 1 Cf1 – 2000 Hz Cf2 – 2000 Hz Cf – 1400 Hz 
Stopband frequency 2 Cf1 + 2000 Hz Cf2 + 2000 Hz Cf + 1400 Hz 
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The filters used in this step are moving filters, in the sense that the filter specifications are 
varied with respect to excitation frequency in real time.  The central frequency (Cf) of the cascaded 
filter will be the excitation frequency.  The magnitude response of these filters for one Cf is shown 
in Fig. 5.13, 5.14 and 5.15.  The filtered “signal” and “noise” data is shown in Fig. 5.16. 
 
Fig. 5.13: Magnitude Response of BPF I (Cf1 =162.3 kHz). 
 





Fig. 5.15: Cascaded FIR filter magnitude response at (Cf =162.9 kHz). 
 
Fig. 5.16: Left – “Signal” data after step 3, cascaded band pass filtering.  Right – “Noise” data 
after step 3. 
Step 4 – Quadrature mixing and magnitude calculation 
 The filtered signal from the bandpass filter is then quadrature mixed by multiplying with 
two sinusoid signals in quadrature phase relation at the excitation frequency and magnitude of the 
mixed signals are calculated in order to isolate the frequency component of interest as shown in 
Fig. 5.17.  If Vr is the filtered signal with sensor resonant frequency ωr and Vs is the excitation 
signal at frequency ωs : 
)sin()( ttvV rr ω=                                                         (5.9) 
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)sin( tvV sas ω=                                                       (5.10) 
After mixing the signals will be: 
ttvtvX srsra )cos()cos()(5.0 ωωωω +−−=                                   (5.11) 
ttvtvY srsra )sin()sin()(5.0 ωωωω ++−=                                    (5.12) 
Magnitude M, is calculated by: 
22 YXM +=                                                 (5.13) 
 
Fig. 5.17: Quadrature mixing and calculation of magnitude. 
The magnitude of the quadrature mixed signals is shown in Fig. 5.18. 
 
Fig. 5.18: Left – “Signal” data after step 4, quadrature mixing (amplitude).  Right – “Noise” data 
after step 4, quadrature mixing (amplitude).  
Step 5 – Lowpass filter 
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 In this step, high-frequency components after the quadrature mixing are removed by using 
a low pass filter.  This process isolates the signal “envelope”.  This low pass filter is also an 
equiripple filter designed using the Remez exchange algorithm with passband frequency of 1 kHz 
and stopband frequency of 3 kHz.  The magnitude response of the filter is shown in Fig. 5.19.  The 
traces after this step are shown in Fig. 5.20. 
 
Fig. 5.19: Magnitude response of the Lowpass FIR filter used in step 5. 
 
Fig. 5.20: Left – “Signal” data after step 5, low pass filtering.  Right – “Noise” data after step 5. 
 Group Delay Compensation: Implementation of the filters in step 3 and step 5 results in an 
inherent group delay.  It is important to compensate for this effect in order to recover the signal 












                                                     (5.14) 
where 𝜃𝜃 is the phase response of the filter and  (dθ/df) is the slope of the unwrapped phase response 
of the filter.  For a filter with a linear phase response, the slope will be constant and thus the group 
delay is constant.  Flow diagram for calculation of GD is shown in Fig. 5.21. 
 
Fig. 5.21: Flow diagram on the calculation of group delay. 
Unwrapping the phase response followed by linear fitting and calculation of slope is illustrated in 
Fig. 5.22 for the LPF used in step 5.   
 
Fig. 5.22:  Phase response of the LPF (Left). Unwrapped phase response (Right) to facilitate 
calculation of group delay. 
The number of samples delayed due to the group delay can be calculated by multiplying group 
delay with the sampling rate.  Group delay compensation is achieved by zero padding the same 
number of samples at the end of original signal before filtering and deleting the same number of 
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samples from the beginning of filtered signal [Bor10].  This is illustrated in Fig. 5.23, 2.24 and 
5.25 for a typical case for BPF II. 
 
Fig. 5.23: Signal with zero padded data at the end of the data trace. 
 




Fig. 5.25: GD compensated data after removing the initial samples. 
In the case of the LPF, padding a constant value can also help to minimize the distortion 
due to filtering.  Constant padding similar to the zero padding and in this case extra data points are 
added at the beginning of the data trace.  In this data trace, the first element 6.4 is duplicated and 
padded in the beginning.  The data trace is also padded with zeroes at the end as shown in Fig. 
5.26.  It was experimentally found that this constant padding along with the zero padding helps in 
minimizing the distortion of the signal while using the filter and helps to recover the sensor signal 
more efficiently. 
 




Step 6 - Selective Kalman Filtering 
By using a Kalman filter (KF), the state of a process (system) can be estimated by using 
the observation, knowledge of the system behavior and noise, and a set of mathematical equations 
[Kal60, Grw11, Chu89].  This technique helps to reduce the error in the measurements of the 
system by predicting the expected response.  Good knowledge of the expected response of the 
sensor signal measured, as well as an ability to characterize the noise at every frequency (by 
measuring over a longer period of time than the ringdown signal is substantial), helps to implement 
the KF efficiently.  The KF is used allowing the noisy ringdown signal to be smoothed and noise 
to be suppressed substantially.  The response of a magnetoelastic sensor excited via a time domain 
decoupled signal – and after the envelope extraction described in the processing steps 1 through 5 
– is a first order exponentially decaying signal.  This known fact that the system response is a 
ringdown signal is exploited here in implementing the KF.  Based on the general Kalman filtering 
principle explained in the appendix, it is implemented here for one-dimensional data. 
 A couple of steps are performed before implementing the KF to ensure its efficient usage.  
First, there is a DC component, equivalent to the average noise amplitude, is present in the 
observed measurements after quadrature mixing.  This is eliminated by subtracting the average 
noise value from the “signal” and “noise” data sets.  This brings the noise to randomly oscillate 






Fig. 5.27: Results of DC shifting. Left – Signal data. Right- Noise data. 
  Secondly, the ringdown envelope before Kalman filtering has distortion due to filter 
transients from the previously implemented bandpass cascaded filter and low pass filter.  The 
response in this portion of the signal is not well matched with a first order ringdown, so the Kalman 
filtering is not advantageously applied to this portion of the signal.  Distorted initial samples were 
set aside prior to the execution of the Kalman filter as shown in Fig. 5.28.  The number of samples 
over which this transient distortion takes place is consistent from measurement to measurement 
and is a characteristic of the digital filters used.  
 
Fig. 5.28: Distorted initial samples were set aside prior to Kalman filtering. Left – Signal data. 





Fig. 5.29: The flowchart illustrating the Kalman filter. 
 The flow diagram of the KF implemented is illustrated in Fig. 5.29.  The current state x for 
the first point is initialized as the first point of the envelope after step 6.  The state covariance and 
Kalman gain are initialized as one and zero respectively, representing full confidence in the 
prediction function.  The filtered point xe predicted using the prediction function f(x) which 
represents typical exponential decay.  The time step, dt, is 1 µs since it is the sampling interval 
used in the data acquisition.  T is the time constant of the exponential decay of the envelope of the 
ringdown.  T is guessed initially from experience and then calculated from an extra Kalman 
filtering step as shown in Fig. 5.9 and used in real time.  Measurement noise covariance rn is 
calculated as the variance of the noise signal around its average value.  This is calculated for each 
frequency during the sweep. This is included in the LabVIEW code via Mathscript TR module.  
These steps are repeated for all the data points to obtain the filtered signal. The Kalman filtered 





Fig. 5.30: Left – Signal data after step 6, Kalman filtering. Right – Noise data after Kalman 
filtering. 
 Summed squared signal amplitude (SSSA): Since the receiving signal is ringing down in 
nature, the signal strength is predominant in initial cycles and the signal strength will be well above 
the noise.  To benefit from all the time that signal is above the noise, the total energy is calculated 
instead of just the maximum amplitude of the ring-down signal.  Using Parseval’s theorem 









                                                         (5.15) 
where xt = amplitude of the signal at sample t after DSP.  The summed squared signal amplitude, 
Es is calculated for the ring down signal for each frequency as:  









                                                     (5.16) 
where xp are the samples (after DSP) taken when the sensor is excited.  The summed squared 










                                                      (5.17) 
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where xq are the samples (after DSP) taken when the sensor is not excited. Signal to noise ratio 





SNR =                                                          (5.18) 
This is illustrated in Fig. 5.31. 
 
 
Fig. 5.31: Illustration of calculation of summed squared signal amplitude. 
The value of n is optimized by calculating the Es and En for all possible values of n at the resonant 
frequency and then evaluating which value of n results in the highest SNR.  This helps to evaluate 
the SNR by taking real-time noise signature into account. 
5.4 Experimental Results 
 Experiments were conducted using the interrogation module to demonstrate the 
effectiveness of the module in overcoming the challenges focused on this work. A ribbon sensor 
is interrogated using the module on benchtop, in vitro, and in situ. The ribbon sensor (12 mm × 1 
mm) is fabricated from 28 µm thick Ni/Fe foil (MetglasTM 2826MB) and assembled in a biliary 
stent using custom-made 3D package.  Magnets (Arnokrome 5, 60 µm thick) were integrated onto 





 The benchtop experiments were conducted to demonstrate the utility of the interrogation 
module for interrogating a magnetoelastic sensor.  In real situations, after the implantation of 
sensor integrated stent in a patient, the stent position and orientation can vary according to the 
position and orientation of the bile duct which can differ from patient to patient.  So, these benchtop 
experiments investigate the dependence of the signal strength on the angle between the 
longitudinal axis of the sensor and the AC excitation field and the dependence of the sensor 
position relative to the transmit/receive coil.  For these experiments, the belt coil (transmit and 
receive coils) was wound around a 20 cm diameter cardboard barrel, and the sensor packaged in a 
stent was placed at the center of the belt coil in air.  
 For the first set of experiments, the angle between the longitudinal axis and the exciting 
AC field was varied, and the change in signal strength was observed as shown in Fig. 5.32.  
 
Fig. 5.32: Change in signal strength with the angle of the sensor with respect to the axis of the coil. 
 The signal strength was reduced significantly to 12% for the case where the sensor was inclined 
45o with respect to the axis of the interrogation coils.  For the 67.5o inclined case, the signal was 
reduced to 1%.  The decrease in the signal strength is close to an exponential with the increase in 
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angle between the sensor axis and the transmit/receive coil axis.  These results indicate that the 
magnetic field generated by the sensor is mostly in the direction of the axis of the coil and hence 
any deviation from it reduces the signal strength considerably.  This indicates the importance of 
having the longitudinal axis of the sensor aligned with the axis of the belt coil. 
 In the next set of experiments, the position of the sensor was varied for several axial/radial 
distances from the center of the belt coil and the variation in signal strength was noted as shown 
in Fig. 5.33.  For this test, the longitudinal axis of the sensor and the axis of the barrel were parallel.   
 
Fig. 5.33: Change in signal strength with the position of the sensor with respect to transmit/receive 
coil. r, and z represents the radial and axial distance respectively from the center of the coil (similar 
to the cylindrical coordinate system).  
For r =0 and z =3, the signal dropped 1.5% compared to r =0 and z =0.  Similarly, as the sensor 
position is moved away from the center of the coil along the axis of the coil, the signal strength 
reduced exponentially.  At the same time, radial position of the sensor shows higher signal strength 
when it is closer to the transmit/receive coil for the case z =0 but vice versa in other cases.  Also 
signal strength reduced to 4% when the coil size is increased from 8” (20 cm) to 12” (30 cm). This 




Fig. 5.34: Change in signal strength when 30 cm diameter transmit/receive coils are used instead 
of  20 cm diameter coils. The signal strength with the position of the sensor with respect to 
transmit/receive coil is also showed. r, and z represents the radial and axial distance respectively 
from the center of the coil (similar to the cylindrical coordinate system). 
That is a 25-fold decrease in signal strength for 1.5-fold increase in wireless range.  In summary, 
the sensitivity of the interrogation module depends on the characteristic pattern of the excitation 
field as well as the sensor field.  More excitation results in more signal strength but at the same 
time, the sensor signal needs to be coupled with the receive coil to detect the signal.  The best-case 
scenario here is to have the sensor close to the transmit/receive coils in the same plane of the coil, 
i.e. no axial distance.   
In vitro experiments 
In vitro experiments were conducted to demonstrate the utility of the interrogation module 
in the scenarios similar to the clinical situation that can be imitated in the lab.  These experiments 
were focused on immersing the sensor packaged in the stent in fluids with varied viscosity and 
imitating the stent occlusion.   
 The sensor integrated stent was immersed successively in water, oil, and then occlusion of 
the stent was imitated using gelatin.   For the fully occluded case, the sensor integrated stent was 
immersed in a gelatin mix. Gelatin mix is prepared by mixing the gelatin powder with water (7 g 
in 72 mL DI water) and allowed to cure in the refrigerator (4oC) for 30 mins.  This imitates a fully 
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occluded stent case. The partially occluded stent is simulated by partially cleaning the gelatin out 
of the stent mechanically using a metal rod of 1.5 mm diameter.  The frequency response in each 
case is shown in Fig. 5.35. The resonant frequency and the quality factor for various cases from 
the in vitro experiments are illustrated in Fig. 5.36.  
 
Fig. 5.35: Frequency response from the in vitro experiments in air, in 1 cS water, in 2 cS oil, 
partially occluded with gelatin, fully occluded with gelatin. 
  
Fig. 5.36: Resonant frequency and quality factor for various cases from the in vitro experiments. 
 The SNR, the resonant frequency and the quality factor of the sensor depends on the 
viscosity of the medium as well as the mass deposition on the sensor.  The SNR decreased 
drastically by 99.5% while immersed in water compared to signal strength in air due to the drastic 
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change in the viscosity of the medium.  However, the reduction in SNR from 1 cS water to 2 cS 
fluid was 34%.  In the implanted situation, the sensor in stent will be immersed in bile solution.  
Bile majorly constitutes water and the viscosity is closer to 1 cS [Jia18b].  The interrogation 
module could detect the signal from the sensor with an SNR of 3020 at a wireless range of 10 cm 
for the case of 1 cS water.   
 The immersion in the fluid was also manifested in a shift in resonant frequency and a drop 
in quality factor.  The resonant frequency in air ≈160.44 kHz is shifted by ≈180 Hz when the sensor 
packaged in stent was immersed in 1 cS DI water. The resonant frequency was shifted by ≈240 Hz 
when the sensor integrated stent was immersed in 2 cS oil. For a partially occluded stent, the 
resonant frequency was shifted by ≈460 Hz while it was ≈480 Hz for the fully occluded case.  
These results indicate that the resonant frequency shifts with respect to mass loading as well as the 
viscosity of the medium.  The quality factor drops by ≈520 from air to 1 cS water and ≈18 from 1 
cS water to 2 cS oil.  When the stent was fully occluded with the gelatin the quality factor dropped 
by ≈150, the SNR dropped by 99.67% and the resonant frequency was shifted by ≈450 Hz 
compared to case where the sensor is in 1 cS water.  This significant change in quality factor and 
the shift in frequency illustrates that the sensor can indicate occlusion in the stent clearly. 
In situ experiments  
 In situ experiments were conducted to demonstrate the utility of the interrogation module 
in situ.  For in situ tests, a laparotomy was performed on a euthanized swine, and the bile duct was 
located.  A sensor integrated stent was placed into the bile duct, and bile was injected into the stent 
to mimic the real environment.  Interrogation coils were placed around the porcine carcass as 
shown in Fig. 5.37.  The coil had an approximate elliptical shape with minor and major diameters 
of 18 cm and 23 cm, respectively.  The frequency response in terms of SNR from the in situ 
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experiment is shown in Fig. 5.38. 
 
Fig. 5.37: Schematic of the coil set-up in situ and the photo of the coil belt around the porcine 
subject. 
 
Fig. 5.38: Comparison of frequency response from benchtop experiment in the air and in situ 
experiment. The normalization factor is 508. 
 
The resonant response was detected successfully using this interrogation module with an 
implanted wireless range of ≈10 cm with an SNR of 376.  Compared to previous interrogation 
systems reported, these results represent a 1.3-fold increase in wireless range and a 54-fold increase 




In vivo experiment 
 The magnetoelastic sensor (8.25 mm × 1 mm footprint) was fabricated by bonding one 28 
µm thick Metglas 2826MB layer with two 60 µm Arnokrome 5 mass loads.  The bond was 
achieved with an Au/In transient liquid phase approach (From Chapter 3).  The mass loads were 
magnetized to provide the required DC bias. The sensor was then coated with Aluminum Oxide 
and Parylene for corrosion protection and biocompatibility. The sensor must be packaged for 
protection during endoscopic deployment. A custom-made 3D-printed polymer-metal package 
(M3 crystal resin reinforced by Nitinol wires) was used for protection and for integrating the sensor 
to the stent (see Chapter 4). 
 The test protocol was approved by the University of Michigan IACUC (protocol #6901). 
The subject of the in vivo test was a female domestic swine (25 kg). Before implantation, the swine 
was sedated, and an intravenous catheter was placed into an accessible vein on the ear. Pre-
operative analgesia was administered through this catheter. After that, the swine was intubated and 
placed on isoflurane anesthesia. Vitals of the subject were continuously monitored using 
temperature monitor, pulse oximetry, and electrocardiogram. A heat source (water-circulated 
heating pad) was also used to keep the vitals normal.  
 The biliary stent was implanted in the bile duct by a standard endoscopic procedure. The 
endoscope (Olympus TJF Type Q180V side-viewing duodenoscope), was guided through the 
mouth and esophagus of the subject, to the stomach, and finally to the duodenum. The side viewing 
camera at the end of the endoscope was used to locate the position of the biliary orifice. Saline was 
injected through the endoscope to clear the camera view as necessary. Once the biliary orifice was 
located, a guidewire along with the catheter was placed through the bile duct. A radiographic dye 
was injected through the catheter into the bile duct. The dye allows the internal structures to be 
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observed via radiogram (X-ray, fluoroscopy) to confirm the cannulation of the bile duct. The 
introducer assembly, along with the loaded stent, was then loaded onto the back end of the 
guidewire and fed through the endoscope. Once the proximal end of the stent was aimed at the 
biliary orifice, the introducer assembly is used to push the stent into the bile duct. The fluoroscopic 
image after implantation is shown in Fig. 5.39. 
 
Fig. 5.39: Fluoroscopic image of the stent after implantation in the swine. 
 
 Next, for the interrogation, the transmit/receive coils were wrapped around the subject, as 
shown in Fig. 5.40. The frequency response of the sensor in vivo compared to the response acquired 
on the benchtop is illustrated in Fig. 5.41.  
 
Fig. 5.40: Interrogation in progress. Interrogation coils are wound around like a belt on the swine  




Fig. 5.41: Sensor response in vivo, benchtop in air and water. 
The quality factor decreased from 178 (in water) to 127 (in situ), and the resonant frequency 
shifted from 179.3 kHz (in water) to 178.2 kHz (in situ). The SNR of this measurement was ≈108. 
The coil dimensions in vivo were slightly different from benchtop experiments due to the swine 
anatomy. The interrogation times (Ti) for benchtop tests were ≈34 s, while that of the in vivo was 
≈336 s. The decrease in quality factor and the resonant frequency is due to the sensor being 
immersed in bile rather than water; bile is more viscous than water. These results indicate the 
sensitivity of the sensor with respect to the medium in which the sensor is immersed.   
 The coils were then placed with an axial offset of ~5 cm with respect to the sensor position 
to mimic the clinical situation where the coils could be misplaced with respect to the position of 




Fig. 5.42: Sensor response in vivo with aligned coils and with an axial offset ~5 cm, interrogation 
time ≈340 s. 
The measured resonant frequency only changed by 0.3 kHz (0.17%) while the quality factor 
changed by 30. The interrogation time was ≈340 s. Even the misaligned coils could detect the 
signal with an SNR of ~4×107.  
 Next, the interrogation coil size was increased to mimic the increased waistline of a larger 
patient. The coil size was increased by inserting an inflated airbag between the subject and the coil 
as shown in Fig. 5.43. The frequency response in these cases is also shown in Fig. 5.44. 
 





Fig. 5.44: Sensor response for increased coil diameters mimicking patients with a larger abdomen,  
interrogation time ≈336 s. 
Increasing the coil dimensions from 10.75” × 6.25” (major and minor elliptical diameters, 27.3 cm 
× 15.9 cm) to 12” × 10.5” (30.5 cm × 26.7 cm) decreased the SNR to 25% of the previously 
measured value, but the resonant frequency stayed within 0.4 kHz with a change in the quality 
factor of only 2. A further coil dimension increase to 16.5” × 13.5” (41.9 cm × 34.3 cm) resulted 
in a decrease of SNR to 15% of that measured with the initial coil dimensions. The shift in resonant 
frequency was only 0.4 kHz with a change in the quality factor of 15. The interrogation time was 
≈336 s. The system could characterize the sensor with an error of ±0.17% in resonant frequency 
and ±10.6% in quality factor. This indicates the consistency in the results measured using this 
interrogation system, despite shifts in orientation and size of the coils. 
5.5 Summary and Conclusions 
 In this chapter an interrogation module for the application of magnetoelastic sensor 
for biliary stent monitoring is discussed.  Experiments were conducted to demonstrate the utility 
of this module on the benchtop, in vitro, in situ and in vivo.  The benchtop experiments investigate 
the effects of sensor alignment as well as position with respect to the transmit/receive coils in the 
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interrogation module. It was found that the sensor must be aligned axially as well as positioned 
closer to the coils for maximum sensitivity. Further in vitro were conducted mimicking the real 
scenario of occlusion of the stent.  Sensor signals from these experiments indicated that the 
occlusion of the stent could feasibly be related to frequency shift and change in quality factor and 
SNR.  Finally, successful in vivo experiments were conducted detecting signals from a 
magnetoelastic sensor implanted in a live animal. The system could detect the signal at a wireless 
range of ≈17.1 cm, and a signal to noise ratio of ≈106 was achieved with an interrogation time of 
336 s.  These are the first reported signals from a magnetoelastic stent-integrated sensor implanted 





6 Chapter 6: Conclusions and Future Work 
  This chapter summarizes the conclusions drawn from the efforts in the development of the 
two magnetoelastic systems in this work: (i) a magnetoelastic system for mitigation of glaucoma 
valve encapsulation and (ii) a magnetoelastic system for biliary stent monitoring. Major 
contributions to the general field of knowledge from these efforts are also summarized here. 
Finally, potential improvements for these systems are identified as future work. 
6.1 Summary of This Work 
Two magnetoelastic systems were developed for implantable biomedical applications, and 
they were investigated in detail and demonstrated in vitro, in situ, and in vivo. The challenges in 
the implanted module were identified and addressed to improve the implant robustness – both in 
terms of mechanical structure and signal strength. The interrogation challenges for these implanted 
devices were surmounted, resulting in enhanced performance of these systems in their respective 
applications. The in vitro, in situ and in vivo experiments proved the robustness of the systems and 
their clinical utility. 
6.1.1 Magnetoelastic system for mitigation of glaucoma valve encapsulation 
The development and demonstration of the magnetoelastic system for mitigation of 
glaucoma valve encapsulation included investigation of the actuator-mounted glaucoma valve 
(implanted module) as well as the interrogation module. Regarding the implanted module, the 
challenges in terms of mounting the actuator on to the valve and corrosion protection were tackled. 
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The interrogation module was developed utilizing a physical domain decoupling approach and 
optimized hardware implementation for improved signal acquisition from the implanted device. In 
vitro experiments performed with the system demonstrate a signal-to-noise ratio of ≈140. In situ 
experiments, performed with the actuator-integrated valves implanted in porcine eyes, achieve a 
signal to noise ratio of 3-6. These are the first recorded acoustic signatures through tissue from a 
magnetoelastic device in an implanted environment. In vivo experiments were performed and the 
results combined with the in situ results indicated that the magnetoelastic system does not 
adversely affect the health of the animal and can feasibly provide sufficient wireless range after 
implantation. 
6.1.2 Magnetoelastic system for biliary stent monitoring 
The development and demonstration of the magnetoelastic system for biliary stent 
monitoring included investigation of the sensor/package design and fabrication and its integration 
to the stent (implanted module) as well as the interrogation module. The challenges tackled in 
terms of the implanted module include sensor miniaturization to reduce the implant footprint 
considerably by a novel sensor design. The challenges towards packaging the stent for protection 
during deployment were also overcome and a novel hybrid sensor package was designed and 
fabricated. Finally, the challenges in terms of interrogation for improved signal acquisition were 
addressed, and a module was developed with careful hardware integration and implementation of 
several signal processing techniques.  
One of the challenges for the implanted module was sensor miniaturization. A novel 
miniaturized, self-biased sensor with preserved frequency was designed and fabricated. The sensor 
structure employed targeted mass-loading to achieve these features. The sensor was characterized 
in vitro for detection of the sludge accumulation, and sensor sensitivity was analyzed.  The ratio 
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of the shift in resonant frequency to the quality factor was found to be well-correlated to the 
occlusion. The receiver-operator characteristic for this parameter indicated an accuracy of 97.84% 
for zero false positive rates, with a detectable threshold of 50% decrease in flow rate through the 
stent. 
The implanted module was also tailored to provide sensor protection during deployment. 
The introducer used during endoscopic deployment can damage the sensor; hence, protective 
packaging is a must. Also, the stent undergoes tight curvature during deployment, which can 
damage the sensor, and the implanted stent is also under curvature imparted by the inherently 
curved bile duct. These challenges were addressed using a hybrid package which consisted of a 
polymer structure reinforced with highly elastic Nitinol wires. The bending tests carried out on the 
packaged-sensor-instrumented stent proved that this hybrid package overcomes these challenges.  
The effect of the packaged sensor itself on the occlusion dynamics was also investigated 
by carrying out in vitro tests, including culturing of bacteria in bile and flowing the mixture through 
both package-instrumented stents and normal stents. Non-inferiority statistical tests conducted on 
these results indicated that the instrumented stent is non-inferior to the normal stent in terms of the 
occlusion time for a p-value <0.05. 
 The interrogation module for biliary stent monitoring was developed to include a time 
domain decoupling approach along with careful hardware implementation and a series of digital 
signal processing techniques.  These features addressed the challenges of signal feedthrough, 
wireless range, and clinical utility. Finally, the complete magnetoelastic system was successfully 
implemented in an in vivo demonstration. The instrumented stent was implanted in the bile duct 
of a live pig via endoscopy. At a wireless range of ≈17.15 cm, a signal to noise ratio of ≈106 was 
achieved with an interrogation time of 336 s.  These are the first reported signals from a 
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magnetoelastic stent-integrated sensor implanted in a live animal via endoscopy. 
6.2 General Contributions to the Field of Knowledge 
Several techniques developed in this work can be potentially extended to other general 
applications as well. The techniques used in developing the implanted module for these systems 
and also the interrogation modules can be extended to improving the system-level performance of 
any transducer-based systems. 
The novel magnetoelastic sensor introduced in this work can potentially be used in any 
applications that require a miniaturized wireless sensor for sensing mass loading/viscosity. A 
functionalized sensor can extend its potential to immunosensing applications and sensing of other 
physical parameters. Specifically, the concept of targeted mass loading for self-biasing the sensors 
while preserving the resonant frequency is attractive for miniaturized wireless sensor applications.  
The preservation of resonant frequency despite miniaturization may also enable new anti-theft tags 
that can tag smaller items or be applied more discretely while leveraging the same 58 kHz 
interrogation infrastructure already in place.  The fabrication technique of In-rich transient liquid 
phase bonding can also be extended for bonding materials in general. The hybrid package 
developed in this work introduces the use of a combination of materials with different mechanical 
properties in the context of applications requiring challenging deployment demands. 
With respect to the development of interrogation modules, the optimized hardware 
implementation and the associated signal processing techniques can be extended to 
test/characterization modules in general for characterizing various types of transducers. For 
example, the interrogation module developed for the mitigation of glaucoma valve encapsulation 
can be used in part for characterizing any transducer that emits acoustic signals. Also, the 
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interrogation module developed for biliary stent monitoring can be used for communicating with 
any magnetoelastic transducer at a greater wireless range. The signal processing techniques like 
Kalman filtering used in this work can be extended to any signal data set for improving the signal 
to noise ratio. 
In vitro experimental method mimicking the occlusion in stent along with the sensor 
characterization results are reported for the first time. This type of approach could enable more 
rapid stent technology development in general. 
6.3 Future Work 
6.3.1 Magnetoelastic system for mitigation of glaucoma valve encapsulation 
Improvement in interrogation performance of the acoustomagnetic module introduced in 
this work (Chapter 2) in terms of wireless range is a possible future endeavor. This will allow 
extending the use of the same interrogation module for in vivo experiments as well with a better 
controlled feed-back method. This feedback enabled module will allow better understanding of the 
encapsulation dynamics and potential improvements in the system. Also, more in vivo experiments 
in the future can give more information about the effect of the liquid actuation and subsequent 
mitigation of the encapsulation. 
6.3.2 Magnetoelastic sensor for biliary stent monitoring 
The sensor introduced in this work performed with a signal to noise ratio of ≈106 at a 
wireless range of ≈17.15 cm. This indicates that there is a huge potential for further sensor 
miniaturization. Several miniaturized sensors, each with a different resonant frequency, can be 
deployed at critical locations along the inner surface of the stent, and this will allow for the 
detection of sludge build-up and occlusion locally. Adjusting the mass loading carefully also 
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allows for controlling the resonant frequency. A combination of these can potentially result in 
development of a sensor array for measuring the entire inner lumen of the stent. The development 
of miniaturized sensors tailored to specific operating frequency ranges as well as an array of these 
sensors integrated with the stent will be a part of future work. The hybrid coating investigated  in 
this work could protect the sensor upto a week or so without any obvious performance decline. 
But the signal performance declined for longer period of time due to corrosion. An improved 
coating method must be explored based on the reported results for corrosion protection for extend 
time period. 
6.3.3 The in-stent hybrid package for biliary stent monitoring 
The in-stent hybrid package could protect the sensor during deployment, but still the signal 
was attenuated due to the transfer of stresses during deployment to the sensor. Further 
modifications to the hybrid package in terms of improving its performance is a potential area for 
future work. A network of packages for the array of sensors mentioned in the previous section can 
also be investigated. Another prospect is in completely avoiding the need for a package by 
modifying the stent itself. A smart stent that has a network of sensors mechanically embedded 
could avoid the use of the package altogether and simplify the implanted module.    
6.3.4 The interrogation module for biliary stent monitoring 
The interrogation module developed in this work for biliary stent monitoring could 
improve the performance compared to previous modules used for this application. However, there 
is still room for further performance enhancement in terms of customizing the hardware and 
including advanced signal processing techniques.  The development of a custom magnetoelastic 
interrogation system, including both analog/digital parts replacing the research-grade hardware 
used in this work is a potential future work.  
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The analog part will mainly include a PCB, consisting of voltage regulators, a buffer 
amplifier, a buffer inverter IC switch, and a low noise amplifier. The PCB will replace the existing 
buffer amplifier, switch/protection circuit, and the LNA. This will effectively reduce the 
complexity and cost of the analog circuitry and associated power supplies while increasing the 
robustness and potentially the performance. The design will enable a single device to replace 
several previously used components, thus reducing the usage of cables and increasing the usability 
and potentially the signal clarity due to enhanced power supply regulation and band-specific 
analog filtering. 
The digital portion of the hardware will focus on digital signal processing program and 
hardware implementation with a single-board computer, Direct Digital Synthesizer (DDS), and 
analog-to-digital converter (ADC). The digital signal processing program written in LabVIEW can 
be translated to other languages as necessary, including advanced digital signal processing 
techniques. The single-board computer will run on its specific language, the DDS will act as a sine 
wave generator, and the ADC will help to read out the signal amplified by the analog part. The 
single-board computer will need to have real-time control and timing capabilities for synchronized 
excitation and detection. A replacement for the currently used NI-PXIe (a combination of sinewave 
generator, data acquisition, and signal processing device) must provide the following functions: 
analog to digital conversion, transmit waveform generation, data storage, digital signal processing, 
logic control, etc. 
Ideally, the combination of the products of the analog portion and digital portion would 
result in an inexpensive, self-contained device that is able to drive the coils and measure the 
response from a magnetoelastic sensor. This new interrogation module will help to move the 
current research to the market. The module would no longer need expensive research-grade 
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hardware (LNA, NI-PXIe, multiple DC supplies). The new module would be self-contained and 
manufacturable in volume at a reasonable price. 
6.3.5 The in vitro, in vivo and clinical experiments for biliary stent monitoring 
The in vitro experiments with the magnetoelastic system discussed in Chapter 4 proved the 
non-inferiority of the instrumented stent with respect to a non-instrumented stent in terms of 
occlusion time. Also, these experiments showed the change in resonant characteristics of the 
sensor, specifically the quality factor and resonant frequency, after occlusion as well. However, 
continuous monitoring of the stent is required for a better understanding of the occlusion 
development inside the stent. The future work on in vitro experiments can follow the same 
procedure of bacterial culture and flow set-up but must develop real-time methods for quantifying 
the occlusion and compare the sensor response. The flow rate through the stent for a constant 
pressure head could be one way for quantifying the occlusion, but it may also destructively affect 
the occlusion itself. Observation of the change in sensor characteristics over time could be an 
alternative way to understand occlusion development in detail.  
The in vivo experiments mentioned in Chapter 5 achieved the first recorded magnetoelastic 
system demonstration targeted towards biliary stent monitoring from a live animal. Continuous 
and long-term monitoring of the implanted sensor could provide more information on occlusion 
development as well as the health effects of the implanted module for a live animal. Several of 
these in vivo experiments will be good precursor set of experiments before clinical use in humans. 
6.3.6 Safety of magnetoelastic materials during Magnetic Resonance imaging (MRI) 
 MRI is a generally used diagnostic tool in body tissue imaging. Conductive or magnetic 
materials implanted inside the body pose a risk of electromagnetic heating due to exposed 
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radiofrequency magnetic fields from the MRI tool. This radiofrequency heating can be either due 
to eddy current formation or hysteresis loss. Preliminary FEA simulations have indicated that the 
rise in temperature due to eddy current heating is well within the International Electrotechnical 
Commission (IEC) guidelines [Pep15a]. More FEA simulations for the specific designs of the 







Appendix A: Double layer mass loaded sensors 
 As discussed in this Chapter 3, miniaturizing the sensor is desirable to minimize the 
obstruction to the bile flow through the stent, to reduce the impact of the sensor on the longitudinal 
bending stiffness of the stent, and for enabling the use of multiple sensors along the length of the 
stent for spatial resolution of sludge accumulation.  However, miniaturizing the sensor drastically 
reduces the signal strength.  A decrease in sensor length to 75% of the initial value results in a 
drastic reduction in the signal strength to 12% of its initial value, and a length decrease to 50% of 
the initial value results in a signal reduction to 3.2% of its initial value [Jia18b].  This significant 
reduction in signal strength poses a serious challenge in miniaturizing the sensors.   
One of the strategies to overcome this challenge is to use double layer sensors, formed by 
tightly bonding two single-layer sensors.  Bonding two single layer sensors effectively doubles the 
material and is expected to result in double the signal strength (and quadruple the signal energy).  
Bonding the layers together, rather than simple stacking of the layers, is necessary in order to 
ensure that any mass loads on the top layer are mechanically coupled to all layers.  Au/In Eutectic 
bonding is used to bond the sensor layers.  Layers of Au and In was deposited on to the sensor 
(Metglas 2826) by physical vapor deposition and electroplating, and the Metglas layers were 
bonded under compression at 200oC in a vacuum environment.  Detailed fabrication steps are 
illustrated in Fig 4.1.  Aggressive cleaning between each layer deposition (e.g. plasma stripping) 
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and to maintain clean bonding surfaces by carrying out as much of the process as possible within 
the Lurie Nanofabrication Facility cleanroom. 
 
Fig. A1: Schematic of layers involved in double layer sensors with Au-In TLP bond 
 
Fig. A2: Fabrication steps of double layer sensors using Au-In TLP bond 
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Six double layer sensors (8.25 mm x 1 mm were characterized (8d1-8d6). The setup used for 
characterization is shown below. The coil was made of 10 turns each for transmitting coil as well 
as receiving coil. The coil diameter is 3.5 cm, and the width of the coil was 2.2 cm for total 20 
turns. Labview code ‘BiliaryStentSensor_v3’ is used. Excitation amplitude is varied with 
frequency to keep the excitation current through the transmit coils is consistent, 43 mA (peak to 
peak) in this case. The Impulse time and ring down time used are 4 ms each. Commercial 
Helmholtz coils were used for DC bias (conversion factor 1 A≈1 G). The interrogation system 
used is shown in the figure below. Note that the BPF on LNA was kept ‘none’ for these 
experiments. 
 
Fig. A3: Interrogation system used for characterization 
Mass loaded double layer sensors were fabricated and characterized. These sensors (8.25 mm x 1 
mm) have mass loads (1 mm x 1 mm) at the two ends.  The sensor is fabricated from double layer 
Metglas (Total thickness of 68 µm), and the mass at the two ends are made of double layer 
Arnokrome 5 (300 Oe coercivity, mass thickness of 150 µm). The following sections discuss 
experiments with mass loaded double layer sensors of 1 mm long mass loads and 1.5 mm long 




Fig. A4: Schematic of layers involved in the fabrication of  mass loaded double layer sensor 
using Au-In TLP bond 
 
Fig. A5: Fabricated mass loaded double layer sensors using Au-In TLP bond 
 Seven mass loaded double layer sensors (total dimension: 8.25 mm x 1 mm with mass 1 
mm x 1 mm; double layer Metglas and double layer Arnokrome 5 300 Oe coercivity) were 
characterized. The same setup is used for characterization (Fig. A3). After characterization with 
the DC bias applied with Helmholtz coils, the mass-loaded resonators were magnetized along their 
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length with the ASC Scientific Impulse Magnetizer (long coil, 100 V impulse, corresponding to 
~10 kGauss peak flux density). The resonators were characterized again in the same setup, without 
any bias applied by the Helmholtz coils.  Note that the Helmholtz coils were still in the setup and 
connected to the same power supply, just that the current from the supply was turned off (It was 
observed to be the same as when the supply was set to 0 A). 
 Two sensors of longer mass loads were tested in this part (total dimension -9.25 mm x 1 
mm with mass 1 mm x 1.5 mm; double layer Metglas and double layer Arnokrome 5 300 Oe 
coercivity). Same interrogation module described in Fig. A3 is used. For a complete comparison, 
Single layer sensors were also fabricated and characterized. Table 1 lists the complete set of 
observations of single layer sensors (8s1 through 8s5) with highest signal strength, resonant 
frequency and quality factor (from plot) for each sensor at their optimized DC bias, along with 
observations from the previous shorter mass loaded double layer sensors (8m1 through 8m8), 
double layer (8d1, 8d2) and longer mass loaded double layer sensors (9m1, 9m2). 
 




Table A1: Summary of observations on sensor characterization. 
























8m1 17.1 0.0147 161.55 269 17.1 0.0123 161.5 269 Self 0.00117 162.4 232 Self 0.0039 162.25 324 
8m2 13.8 0.000664 161 201 17.1 0.000175 161.25 215 Self 0.00054 161.7 231 Self 0.00074 161.8 270 
8m3 13.8 0.000012 162.3 74 13.8 0.000048 161 196 Self 0.00001 162.1 74 Self 0.00001 162.5 64 
8m4 13.8 0.0634 162.3 405 13.8 0.0829 162.3 405 Self 0.0244 162.65 406 Self 0.027 162.65 464 
8m6 17.1 0.0129 159.65 319 13.8 0.0098 159.9 290 Self 0.0026 160.15 400 Self 0.0011 160.25 320 
8m7 17.1 0.00568 159.9 290 19.7 0.00351 159.75 245 Self 0.00138 160.45 267 Self 0.000646 160.65 247 
8m8 13.8 0.0127 161.2 358 17.1 0.0112 161.15 293 Self Damaged Self Damaged 
9m1 13.8 0.03516 136.3 340 17.1 0.02862 136.3 340 Self 0.00567 136.6 303 Self 0.00177 137 228 
9m2 13.8 0.0697 136.55 390 10.2 0.07319 136.65 390 Self 0.034 136.65 390 Self 0.0349 136.8 390 
8d1 17.1 0.44 233.3 650 
 
8d2 13.8 0.55 236.5 720 
8d3 17.1 0.179 228.5 457 
8d4 17.1 0.264 228.5 571 
8d5 17.1 0.364 235.4 588 
8d6 17.1 0.35 234.9 587 
8s1 6.8 0.0303 267.5 232 
8s2 3.4 0.092 271.8 452 
8s3 5.1 0.041 269.5 300 
8s4 3.4 0.0707 270.8 416 








 The performance of the mass loaded sensors was poor compared to the double layer sensors 
and single layer sensors.  Some possible sources of this poor performance include: damping added 
by the exposed gold layer. The performance of the longer mass (1 mm long) loaded sensors was 
better. It is possible that more mass loaded material helps to attain DC bias better than the shorter 
mass loads.   
 Delamination issue: In most cases, the major delamination occurred between the Metglas 
layer and the evaporated chrome layer (Fig. A6.). There was high residual stress observed after the 
gold plating which essentially curved the Metglas substrate. This could be a reason to delaminate 
all the layers from Metglas. Also, the diffusion of the Cr adhesion layer to the gold could be another 
reason for delamination.   
 





Appendix B: General Principle of Kalman Filtering 
 A general Kalman filtering approach is described in this appendix. In Kalman filter, for a 
discrete single output system, the state equation is defined as: 
)())(()1( nwnxfnx +=+                                                  (B.1) 
where w is Gaussian noise with covariance Q (process noise covariance), f(x) is the state function.  
Q indicates the confidence level of the defined f(x) to the process behavior.  Q = 0 will imply that 
the state function is expected to be exactly as f(x). In the case of response from a magnetoelastic 
sensor, f(x) is the envelope of the ringdown signal received from the magnetoelastic sensor, and 
Q = 0 is taken here since this form of f(x) is expected with surety.  Only the exact value of the 
decay time constant is unknown a priori; this initially guessed value can be improved after one 
iteration of Kalman filtering (as described later).  In this case, the state function f(x) is modeled as: 
)()1()( τ
dt
exf =                                                            (B.2) 
where dt is the time step, and τ is the time constant of the exponential decay of the envelope of the 
ringdown.  Here dt = 1 µs since it is the sampling interval used in the DSP.  τ is estimated from the 
frequency plot generated from previously implemented DSP steps and used in real time.  Now, the 
observation function is defined as: 
)())(()( nvnxgnz +=                                                   (B.3) 
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where v(n) is Gaussian noise with covariance Rn (measurement noise covariance), and g(x) is the 
sensor response.  Rn is calculated as the variance of the noise signal around its average value.  Rn 
and the average noise are calculated for each frequency in real time.  The observations z(n) are the 
measured values.  The algorithm for the Kalman filter is as follows.  For KF, one step projection 
xp is predicted as: 
)( ip xfx =                                                           (B.4) 
where xi is the current state. The covariance of xp is defined as: 
Qfypfyp ip +⋅⋅= '                                                 (B.5) 
where pi is the estimated state covariance (set to 1 for the initial step, or otherwise calculated in 










                                                   (B.6) 
and fy’ is the inverse of fy. Kalman gain is defined as: 
𝐾𝐾 = 𝑝𝑝𝑝𝑝𝐻𝐻′
𝐻𝐻.𝑝𝑝𝑝𝑝.𝐻𝐻′+𝑅𝑅𝑛𝑛
                                                     (B.7) 










                                                     (B.8) 
and H’ is the inverse of H. With these equations, the output state is estimated as: 
))(( ppo xgzKxx −+=                                              (B.9) 
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where z is the observation. and the expected sensor response g(x) is defined as a linear function: 
𝑁𝑁(𝑥𝑥) = 𝑥𝑥𝑝𝑝 
This gives Jacobian H, as: 
𝐻𝐻 = 1                                                                    (B.10) 
(Note that the inverse of H in eq. (7) is set to 0 if H is 0).  Further, the covariance of the projected 
state is updated as: 
)1( HKpp po ⋅−=                                                    (B.11) 
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